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Abstract 
Vancomycin resistance enterococci (VRE) are an important cause of nosocomial 
infections. Presence of VRE in farm animals constitute a reservoir of resistance that 
can spread to humans via the food-chain and is due to extensive use of the growth 
promoter avoparcin conferring cross-resistance to vancomycin. 
Since 2000, the occurrence of VRE among Swedish broilers has increased in the 
absence of any obvious selective pressure as avoparcin has not been used since 1984. 
Also, the increased occurrence seemed to be due to spread of one clone of VRE. 
The work of this thesis confirms that the increased occurrence of VRE is caused 
by the spread of one predominant clone. Both the predominant and the minority 
clones are E. faecium with plasmid mediated vanA gene. 
The vanA gene is transferrable from the predominant and several of the minority 
clones. Thus, the predominance of one clone is not due to that the resistance is 
untransferable from the clones. It also confirms that VRE among Swedish broilers 
have a potential for zoonotic spread of the vanA gene. Plasmid addiction systems are 
most likely not involved in the retention of the vanA gene as there is a near absence 
of such systems among VRE from Swedish broilers. Decreased susceptibility to the 
ionophore narasin can be co-transferred with the vanA gene from the predominant 
and some of the minority clones. Thereby the use of narasin for coccidial 
prophylaxis could contribute to retention of the vanA gene. The traits are probably 
located close to each other so when retaining the decreased susceptibility to narasin, 
the enterococci also retain the vanA gene. 
Broilers arriving to the farms are colonized with VRE persisting in the broiler 
houses. Differences in occurrence of VRE among farms indicate that the occurrence 
of VRE can be reduced. Furthermore, a reduction in the contamination of the 
broiler houses can be achieved by disinfection with a method combining steam and 
formaldehyde. Subsequently, this could reduce the occurrence of VRE in Swedish 
broiler production on the whole. 
Further research should focus on the role of narasin in the VRE epidemiology as 
well as exploring the possibility to eliminate VRE from Swedish broiler production. 
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Dedication 
Till hen – antagligen inte sista gången du ändrar på mina planer. 
Evolution of bacteria towards antibiotic resistance is unavoidable as it represents a 
particular aspect of the general evolution of bacteria. Thus, at the very best, the only 
hope we can have in the field of resistance is to delay dissemination of resistant 
bacteria or resistance genes. 
Patrice Courvalin 
 
 
I drink champagne when I'm happy and when I'm sad. Sometimes I drink it when 
I'm alone. When I have company I consider it obligatory. I trifle with it if I'm not 
hungry and drink it when I am. Otherwise I never touch it - unless I'm thirsty. 
Madame Lilly Bollinger 
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1  Introduction 
Epidemiological knowledge is an important factor in reducing any infectious 
disease. For a zoonotic agent the need for knowledge is not limited to its 
spread from animals to humans. Instead, all aspects of the diseases persistence 
and spread among animals are at least as important. 
1.1  Foodborne zoonoses 
The World Health Organisation defineds a zoonosis as “any disease or 
infection that is naturally transmissible from vertebrate animals to humans 
and vice-versa” (WHO, 2011). The transmission from animals to humans 
can be either direct or indirect (Figure 1). One route for indirect transfer is 
contaminated animal or vegetable food products (Schjorring & Krogfelt, 
2011; Giraffa, 2002). The scenario regarding spread of zoonotic agents via 
the food chain, i.e. foodborne zoonoses, is contamination of human food 
products by organisms from animals which are pathogenic to man. Meat 
products could for example be contaminated by faecal material at the 
slaughterhouses whereas vegetables may be contaminated in the field by 
manure or sewage water used for fertilization and irrigation. 
Normally, it is the agent per se that is zoonotic (e.g. Norovirus, Salmonella 
and Campylobacter spp.). However, regarding antimicrobial resistant bacteria 
it is not only pathogens that could have a zoonotic potential, but also the 
genes encoding antimicrobial resistance in commensals such as Escherichia coli 
and  Enterococcus spp. which may transfer to more pathogenic organisms 
(Schjorring & Krogfelt, 2011; EFSA, 2008b). Here, the scenario is that once 
in the human intestine, the bacteria might colonize and persist or their 
presence may only be transient (Trobos et al., 2009; Berchieri, 1999). Even 
if the animal derived bacteria colonize the human intestine only for a short 
time, this can be sufficient for resistance genes to be transferred to other   10
strains better adapted to colonize humans (Lester et al., 2006). These human 
adapted strains can then persist for long periods and also spread to other 
people. The zoonotic potential of certain antimicrobial resistance genes 
means any resistant bacteria present in farm animals may be considered a 
reservoir for resistance that can spread affecting both veterinary and human 
medicine (Witte, 2000). 
This zoonotic potential is demonstrated by the emergence of resistance 
to streptothricin in East Germany (Witte, 2000; Tschape, 1994; Hummel et 
al., 1986). In 1983, when a streptothricin antimicrobial (nourseothricin) was 
introduced for animal growth promotion in East Germany no resistance to 
that antimicrobial was seen in Enterobacteriaceae from humans or animals. 
After a couple of years, resistance to streptothricin mediated by a transposon 
located gene coding for streptothricin acetyltransferase was found in E. coli 
from pigs. In the subsequent years, resistance spread further and was found 
not only in E. coli from pig farmers but also from healthy people in the 
community as well as in clinical isolates of E. coli. Finally, resistance to 
streptothricin spread to other bacteria and was found in clinical isolates of 
Salmonella and Shigella spp. 
 
Figure 1. Various routs by which zoonotic bacteria can spread between animals and humans. 
The same routes apply also for resistance genes. Illustrations by K. Dahl. 
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1.2  Swedish broiler production 
Broiler production is often illustrated as a pyramid (Figure 2) with the elite 
animals and pedigrees at the top and the broilers in the bottom. The 
production is highly organized and the breeding is controlled by a few large 
international companies. The Swedish Poultry Meat Association (SPMA) 
organises companies within Sweden involved in all parts of the production 
chain (i.e. feed manufacturers, producers of hatching eggs, hatcheries, 
broiler producers and slaughterhouses). The association has around 145 
broiler producers as members. Members of SPMA account for 98-99% of 
the domestic production of about 75 million broilers each year, which is 
about 65-70% of the broiler meat consumed annually in Sweden. 
The Swedish broiler production is dependent on import of day-old 
grandparent birds for breeding parent birds, and later broilers. Currently this 
import is managed by only two companies, Aviagen SweChick AB and 
Blenta AB importing the hybrids Ross from Scotland and Cobb from 
England respectively. In total, there are two hatcheries for parent birds and 
three hatcheries for broilers in Sweden. The broilers and the by-products 
(males from the female line and females from the male line) from the parent 
level are delivered as day-old chickens to the broiler producers. After the 
grow-out period, the broilers are sent to slaughterhouses which are also 
associated to the companies delivering the day-old chickens to the broiler 
producers. 
 
Figure 2. “The broiler pyramid” illustrating the hierarchical 
structure of commercial poultry production. 
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A standard Swedish broiler farm consists of one or several houses, each 
consisting of one to four compartments with a separate service room (Figure 
3). Before entering the service room, personnel should change coverall and 
footwear and wash their hands. At the average farm, around 20 000 
chickens are raised within each compartment and the broilers are sent for 
slaughter when they are about 35 days old. Litter material used is sawdust, 
wood shaving or short cut straw. During the growing period the broilers 
have ad lib access to water and feed. Normally the feed consists of pelleted 
cereals but most producers also feed their broilers with whole wheat in 
amounts increasing by age. When the broilers have been sent for slaughter, 
the houses are thoroughly cleaned and disinfected. Then follows an empty 
period of about one week when there are no broilers at the farm before the 
next batch of day-old chickens arrives. This production system is normally 
referred to as an all-in all-out procedure or batch production. 
All members of SPMA are also, apart from practicing all-in all-out 
procedure, obliged to be enrolled in various health programmes such as the 
Salmonella control programme and the Campylobacter programme. 
 
 
Figure 3. A compartment at a standard Swedish broiler farm. Photo by Eva Berntsson.   13 
1.3  Vancomycin resistant enterococci 
The term vancomycin resistant enterococci (VRE) includes many forms of 
both bacteria and resistances. This is best elucidated by further exploring the 
three words in the term. 
1.3.1  Vancomycin 
Vancomycin is a glycopeptide antimicrobial produced by the soil bacteria 
Streptomyces orientalis (McCormick et al., 1955). It was developed and 
introduced in the 1950s (Reynolds, 1989). Another glycopeptide authorised 
for use in humans in Sweden is teicoplanin (Läkemedelsverket, 2011). 
Glycopeptides interfere with the cell wall production resulting in a 
destabilized cell wall and lysis of the bacteria (Reynolds, 1989). When the 
bacterial cell wall is synthesized, polysaccharide-pentapeptide complexes are 
linked together via a transpeptidation reaction in which the end amino acid 
of the pentapeptide is removed (Reynolds, 1989). Glycopeptides interfere 
with this process by binding tightly to the D-Alanyl-D-Alanin (D-Ala-D-
Ala) end of the pentapeptide and hiding it from the transpeptidase that is to 
catalyse the cross-linking in the peptidoglycan synthesis (Reynolds, 1989). 
Vancomycin is active against most Gram positive bacteria whereas the 
majority of Gram negatives are resistant (Walsh, 2003; French, 1998). It is 
considered a drug of “last resort” and has been classified as critically 
important for human medicine for treatment of patients with severe 
infections with multi-drug resistant Enterococcus spp. and meticillin resistant 
Staphylococcus aureus (MRSA) as the main indications (WHO, 2009). 
Vancomycin is also used for intestinal infections, especially 
pseudomembranous colitis caused by Clostridium difficile where the poor 
absorption of vancomycin when administered orally is advantageous (Kirst et 
al., 1998). 
1.3.2  Enterococci 
Enterococci are intestinal bacteria colonizing humans and other mammals as 
well as birds, reptiles and insects (Martin & Mundt, 1972; Mundt, 1963; 
Sherman, 1937). They are Gram positive, facultative anaerobes, catalase 
negative and non sporeforming cocci occurring either as single bacteria, in 
pairs or in short chains (Fisher & Phillips, 2009; Schleifer & Kilpper-Bälz, 
1984). They can sustain various adverse conditions and can survive for 
several months in the environment (Kramer et al., 2006; Barnes, 1959). 
Until 1984 enterococci were considered a part of the genus Streptococcus, 
even though they were first described and tentatively named enterococci 
(entérocoque) in 1899 (Schleifer & Kilpper-Bälz, 1984; Thiercelin, 1899).   14
Today, 40 different species of enterococci have been described (Euzeby, 
2011). The species most frequent in the intestines of humans are Enterococcus 
faecalis, and to a lesser extent E. faecium whereas the most common species in 
various farm animals are E. faecium together with E. cecorum, E. faecalis, and 
to some extent E. hirae (Klein, 2003; French, 1998; Devriese et al., 1991). 
Even though the first description in 1899 referred to enterococci as 
potential pathogens they were for a long time regarded as harmless intestinal 
bacteria without clinical importance (Fisher & Phillips, 2009; Thiercelin, 
1899). Nowadays however, enterococci are recognised as important 
opportunistic pathogens, especially causing nosocomial infections such as 
urinary tract infections, wound infections and endocarditis (Fisher & 
Phillips, 2009). The clinically most important species in human medicine are 
E. faecalis and E. faecium (Werner et al., 2008). Of these, E. faecalis is the 
most pathogenic species but E. faecium is of increasing importance as it is 
generally more frequently resistant to antimicrobials (French, 1998). 
1.3.3  Enterococcal resistance to vancomycin 
Until today, nine different variants  of vancomycin resistance in enterococci 
have been described (vanA, B, C, D, E, G, L, M and N; Table 1) (Hegstad 
et al., 2010; Lebreton et al., 2010; Xu et al., 2010; Boyd et al., 2008; 
Courvalin, 2006). Among those, the three most common variants are the 
vanA, B and C types with E. faecium carrying the vanA genotype as the most 
common combination (Fisher & Phillips, 2009; Werner et al., 2008). An 
additional variant (vanF) has also been described but thus far only in 
Paenibacillus popilliae (Patel et al., 2000). Since the vanF variant has a high 
similarity in amino acid sequences to the vanA variant, P. popilliae has been 
suggested as a possible origin for vancomycin resistance in enterococci (Patel 
et al., 2000). Other plausible sources are various glycopeptide producing 
organisms, even if genetic differences make an older common source more 
likely (Patel, 2003). 
Common to all variants of vancomycin resistance in enterococci is the 
ability to cause a change in the structure of the pentapeptide incorporated in 
the three dimensional web of peptidoglycans composing the bacterial cell 
wall: from the original D-Ala-D-Ala to either D-Ala-D-Lactate (D-Ala-D-
Lac) or D-Ala-D-Serine (D-Ala-D-Ser) (Courvalin, 2006). This shift results 
in a reduced affinity for vancomycin by 1000 and 7 times respectively 
(Fisher & Phillips, 2009). 
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In all different variants of vancomycin resistance are several genes involved 
in the alteration of the cell wall structure which results in the resistance. The 
number and organisation of these genes are somewhat similar among the 
different variants. For the vanA variant, the genes are organized as in Figure 
4.  VanS is a sensor gene which in the presence of a glycopeptide 
phosphorylate, and thus activate the regulator gene vanR (Courvalin, 2006). 
After activation of the gene complex, VanH mediates production of lactate 
from pyruvate which vanA uses to synthesize the alternative D-Ala-D-Lac 
end of the pentapetide (French, 1998). It is essential for resistance that 
production of the normal D-Ala-D-Ala end of the pentapetide does not 
continue. This is resolved by the vanX and vanY genes where vanX 
hydrolyzes and thereby interrupts the production of the pentapeptides, and 
vanY cleaves the pentapeptides that might still be produced (French, 1998; 
Arthur et al., 1996). In the absence of a glycopeptide, vanS initiates 
dephosphorylation of vanR resulting in deactivation of the gene (Courvalin, 
2006).The function of the vanZ gene is not understood (Courvalin, 2006). 
 
 
Figure 4. Organization of the genes involved in the vanA variant of vancomycin resistance in 
enterococci. Adapted from Courvalin, 2006. 
1.4  Clinical impact of VRE 
The first cases of infection with vancomycin resistant entrerococci were seen 
in 1986 (Leclercq et al., 1988; Uttley et al., 1988). Since then, VRE have 
spread around the world and are now one of the most important causes of 
nosocomial infections, even if asymptomatic intestinal colonization is much 
more common than morbidity (Patel, 2003). When infections with VRE do 
occur, the consequences are often worse compared to infections with 
vancomycin susceptible enterococci. Associations have been seen between 
infections with VRE and increases in therapy failure, length of hospital stay 
as well as mortality (DiazGranados et al., 2005; Patel, 2003). However, 
studies where no significant difference is seen also exist (Garbutt et al., 
2000). 
vanR vanS vanH vanA vanX vanY vanZ  17 
1.5  VRE in farm animals 
Feeding animals low doses of antimicrobials may in certain conditions 
increase their productivity, for example by improving feed conversion and 
decreasing morbidity and mortality caused by clinical and subclinical 
infections (Butaye et al., 2003). The growth promoting effect of 
antimicrobials was first discovered when broiler chickens were fed the 
fermentation leftovers after production of antimicrobials (Stokstad & Jukes, 
1950; Stokstad et al., 1949). Notable is that all use of growth promoters in 
Sweden was forbidden in 1986 by the Feedingstuffs Act (SFS 1985:295). 
The glycopeptide avoparcin was first introduced for growth promotion 
in 1975 (Hammerum et al., 2010). At that time it was used extensively in 
most parts of Europe and the rest of the world with the notable exception of 
Canada and USA where avoparcin never has been approved for animals 
(McDonald et al., 1997). Avoparcin was mainly used for broilers and pigs 
but to some extent also for turkeys, veal calves and other animals 
(Hammerum et al., 2010; Wegener, 1998; Bates, 1997). The extent of 
avoparcin use is demonstrated by data from Denmark where 24 kilograms of 
vancomycin was used in human medicine in 1994, and in the same year 
more than 24 000 kilograms of avoparcin was used for growth promotion 
(Wegener, 1998). A similar example is Australia, where from 1992 to 1996 
less than 600 kilograms of vancomycin but over 62 000 kilograms of 
avoparcin was imported (Witte, 1998).  
As avoparcin confers cross-resistance to vancomycin the (mis)use of 
avoparcin selected for VRE (Bager et al., 1997). Hence, VRE, i.e. E. faecium 
carrying the vanA genotype was common in the intestinal flora of farm 
animals in Europe during the 1990’s (Aarestrup, 1995; Klare et al., 1995b). 
By contrast, since avoparcin has never been approved in Canada and USA, 
VRE had until 2008 never been isolated from farm animals in USA 
(Donabedian et al., 2010). 
When the connection between avoparcin and VRE in farm animals was 
confirmed, the use of avoparcin was discontinued as a precautionary 
measure to avoid further spread of VRE to the community and into hospital 
settings (Anonymous, 1997b). Apart from Sweden, the use of avoparcin in 
Europe ceased first in Denmark, Finland and Norway (Aarestrup et al., 
2000). Later it ceased in Germany and finally in the whole of the European 
Union as a consequence of the Commission Directive 97/6/EC 
(Anonymous, 1997b). Avoparcin has later been banned or phased out also in 
other parts of the world (Hammerum et al., 2010; Lauderdale et al., 2007; 
Yoshimura et al., 1998). Once the use of avoparcin had been discontinued,   18
the prevalence of VRE in farm animals rapidly declined (Aarestrup et al., 
2001; van den Bogaard et al., 2000; Klare et al., 1999). 
The decreased occurrence of VRE in animals after the use of avoparcin 
was discontinued reinforces the theory that if the selective pressure is 
removed, the antimicrobial resistance will disappear (Andersson & Hughes, 
2010; Andersson & Levin, 1999). However, when using selective media (i.e. 
media with vancomycin) VRE could and can still be readily detected 
(Ghidan et al., 2008; Garcia-Migura et al., 2007; Lim et al., 2006; Sorum et 
al., 2006; Novais et al., 2005; Heuer et al., 2002a; Borgen et al., 2000a). 
Furthermore, a recent study modelling persistence of VRE indicates that it 
will be present among farm animals for a long period of time which is also 
in agreement with today’s view on the timeframe of reversal of 
antimicrobial resistance (Johnsen et al., 2011; Andersson & Hughes, 2010). 
Different theories about why VRE persist among farm animals have been 
presented. In Denmark, the use of the macrolide tylosin in pigs was 
suggested to co-select for vancomycin resistance among enterococci since 
the genes encoding the two resistances were located on the same plasmid 
(Aarestrup, 2000). A similar but weaker correlation with co-selection by 
copper resistance has also been suggested (Hasman & Aarestrup, 2005). 
Another explanation that has been suggested is that plasmid addiction 
systems located on the same plasmid as the vanA gene would force the 
bacteria to retain the resistance (Johnsen et al., 2005). 
1.6  Spread of vancomycin resistance 
Spread of vancomycin resistance can be due to dissemination of resistant 
bacteria and for some of the variants also to horizontal transfer of the 
resistance genes (Bonten et al., 2001). Both ways are possible for the vanA 
variant and is among other things of importance for the zoonotic potential. 
Similar strains of VRE have been isolated from pigs and humans (Freitas 
et al., 2011). Furthermore, when the use of avoparcin was discontinued in 
Europe, not only did the occurrence of VRE among farm animals decrease 
but there was also a subsequent decrease in the occurrence of VRE in food 
of animal origin and in the prevalence of human colonization with VRE 
(Klare et al., 1999; Pantosti et al., 1999). 
Transfer of the vanA gene is associated with mediation by a transposon, a 
mobile genetic element that can be incorporated either in the bacterial 
chromosome or on plasmids (Courvalin, 2006; Tamarin, 2004). More 
specifically the genes are located in and transferred by the transposon 
Tn1546 or closely related genetic elements (Courvalin, 2006). Also, the   19 
possibility for in vivo transfer of vancomycin resistance from VRE of animal 
origin to enterococci of human origin in the intestines of humans has been 
described (Lester et al., 2006). Furthermore, in vivo transfer of the vanA gene 
to hospital adapted enterococci has also been demonstrated (Lester & 
Hammerum, 2010). 
1.7  The Swedish situation, human side 
Cases of vancomycin resistant E. faecalis and E. faecium within human 
medicine in Sweden became notifiable according to the Swedish 
Communicable Diseases Act in 2000. From then and until 2006, the 
number of persons colonized or infected varied from 18 to 47 per year, and 
over that period a total of 185 cases were reported (Smittskyddsinstitutet, 
2011). In the autumn of 2007 the number of people colonized or infected 
with VRE increased considerably. The outbreak involved several counties 
over various parts of Sweden and from 1
th August 2007 to the end of 2009 a 
total of 986 domestically acquired cases were reported (SWEDRES, 2010). 
In most parts of the world, VRE of the vanA variant are the most 
prevalent among human cases (Werner et al., 2008). In contrast, the 
majority of the Swedish cases (87%) were E. faecium with the vanB variant 
of vancomycin resistance (SWEDRES, 2010). Moreover, most of these 
isolates belonged to one clone as indicated by identical or closely related 
profiles when analysed with pulsed-field gel electrophoresis (Soderblom et 
al., 2010; SWEDRES, 2010). Notably, Australia also has the majority of 
their cases among humans of the vanB type (Johnson et al., 2010; Bell et al., 
1998). The reasons for the dominance of the vanB type resistance in 
Sweden and Australia are unknown (Soderblom et al., 2010; SWEDRES, 
2010; Bell et al., 1998). Notably, in 2010 the number of cases with vanB 
decreased considerably whereas the number of cases with vanA was stable 
(SWEDRES, 2011).  
There are also indications that VRE disseminate from humans and into 
the environment. VRE of both vanA and vanB type have been detected in 
various samples of sewage (Sahlstrom et al., 2009; Iversen et al., 2002). The 
distribution between E. faecium with the vanA or the vanB gene differed 
between the two studies. The source of the E. faecium with the vanB gene is 
most likely humans. The source of E. faecium with the vanA gene is more 
uncertain even though human cases of vanA type VRE had already been 
reported in Sweden (Torell et al., 1997).   20
1.8  The Swedish situation, farm animal side 
In Sweden, avoparcin was only used for a short period of time from the end 
of the 1970’s until 1984 and the yearly usage by the end of that period was 
between 7 000 and 9 000 kilograms (Wierup et al., 1987). Furthermore, all 
use of growth promoters in Sweden was forbidden in 1986 by the 
Feedingstuffs Act (SFS 1985:295). 
In accordance with the low selective pressure for vancomycin resistance 
by avoparcin use that enterococci in Swedish farm animals had been 
exposed to, VRE were not isolated in samples from Swedish broilers or pigs 
in the middle of the 1990’s (Quednau et al., 1998; Anonymous, 1997a). 
However, in a study conducted 1998 to 2000 the first VRE from Swedish 
farm animals were isolated (Kuhn et al., 2005). In that survey, VRE were 
isolated from 4 out of 150 faecal samples from broilers and 1 out of 306 
faecal samples from pigs. 
In the following years, the occurrence of VRE increased and in samples 
analysed within the Swedish Veterinary Antimicrobial Resistance 
Monitoring programme (SVARM), the proportion of broilers colonized 
with VRE increased from less than 1% in 2000 to over 40% in 2005. In 
addition, all of the isolates were E. faecium w i t h  h i g h  l e v e l r e s i st a n c e to 
vancomycin and the vast majority did also display similar resistance patterns. 
This situation called for further investigations and a number of pilot studies 
were initiated. These studies investigated for example the epidemiology of 
the observed increase including possible ways of introduction, the 
persistence of the VRE at farm level including possible ways of reducing the 
occurrence, as well as prevalence of VRE both at farm level and on broiler 
meat in retail stores (Jansson et al., 2009a; Jansson et al., 2009b; Franklin et 
al., 2005 and unpublished results). 
Until present in Sweden, apart from the single isolate from a pig 
mentioned above, VRE have only been isolated from broilers. Furthermore, 
the proportion of VRE among randomly selected enterococci from Swedish 
broilers is very low with only 4 VRE found among 1666 investigated 
enterococci out of which 1040 are E. faecium (SVARM, 2011). 
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2  Aims of the thesis 
The motivation for this project was a desire to eliminate, or at least reduce 
the occurrence of VRE in Swedish broiler production. In order to succeed 
with this, knowledge about the epidemiology is vital. 
The more specific aims of the project were: 
 To study the increase in the proportion of Swedish broilers colonized 
with VRE, with the hypothesis that it was caused by the spread of 
one clone of VRE. 
 To study the diversity among VRE from Swedish broilers, with the 
hypothesis that similarities exist among the clones. 
 To study if vancomycin resistance in VRE from Swedish broilers is 
transferrable, with the hypothesis that it is transferrable. 
 To study why vancomycin resistance is retained by enterococci in 
Swedish broilers, with the hypothesis that the resistance is linked to 
traits ensuring stable inheritance. 
 To study environmental contamination with VRE on farms during 
grow-out, with the hypothesis that the contamination decreases but is 
not eliminated when broiler houses are cleaned and disinfected 
between batches. 
 To study possibilities for VRE control in Swedish broilers, with the 
hypothesis that elimination from the broiler houses is possible if 
sufficient exposure of the VRE to the disinfectant is achieved.   22
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3  Materials and Methods 
3.1  Sampling procedures 
3.1.1  Caecal samples 
In Paper I, III and IV of this thesis, caecas from broilers were used to 
investigate VRE colonization. The caecas sampled in Paper III and IV were 
obtained through the Swedish Campylobacter programme, whereas the caecas 
sampled in Paper I initially were obtained directly from the slaughterhouses 
and from 2005 and onwards through the Campylobacter programme. Only 
one slaughter group from each broiler house was included, i.e. if all broilers 
within a compartment were not slaughtered on the same day only samples 
from the first group sent for slaughter were included. In addition, only one 
caecum per slaughter group was analysed in Paper I whereas all ten caecas 
available from each slaughter group were analysed in Paper III and IV. 
The Swedish Campylobacter programme is organized by the SPMA and 
covers the majority of broilers raised in Sweden. Within the programme, 
caecas from ten birds in each slaughter group are collected by personnel at 
the slaughterhouses. The caecas are then analysed for the presence of 
campylobacter at the National Veterinary Institute. The rationale for using 
caecas from the Campylobacter programme is that it is a convenient way to 
get samples that are also representative of the Swedish broiler production. 
3.1.2  Environmental samples 
The environment within the broiler houses were sampled with two 
different commercial kits; “Sterisocks humid” and “Sterile cloth” (SodiBox). 
These products were originally developed for the French Agency for Food, 
Environmental and Occupational Health and Safety to sample animal farms 
and food industries for salmonellae and other bacteria. Socks were used to   24
sample the floor of the compartments and cloths were used to sample air 
inlets, air outlets, feed lines and water lines. 
In Paper III, environmental samples were taken from all the sites 
mentioned above. In Paper IV, samples were taken only from air outlets, 
feed lines and water lines. 
3.2  Culturing methods 
3.2.1  Selective media 
All caecal and environmental samples analysed were cultured on selective 
media, i.e. Slanetz–Bartley agar supplemented with vancomycin, and 
incubated at 37°C for 48 hours. Slanetz–Bartley is a medium developed to 
favour enterococci (Slanetz & Bartley, 1957). Depending on the 
concentration of vancomycin used in the media the inhibition of other 
bacteria than VRE is more or less stringent. But the selection of different 
variants of VRE is also affected since they exhibit diverse levels of minimum 
inhibitory concentration (MIC) of vancomycin (see Table 1, page 15). 
In the SVARM programme (hence also in Paper I) the concentration in 
the Slanetz–Bartley agar was 8 mg/L from 2000 to 2002. From 2004 and 
onwards in the SVARM program (and Paper I) as well as in Paper III and 
IV, the concentration of vancomycin in the agar was increased to 16 mg/L. 
That a vancomycin concentration of 16 mg/L was used probably 
inhibited some variants of VRE, for example enterococci with intrinsic 
vanC type resistance. A major concern would be a possible elimination of 
some VRE of the vanB variant, as they can have MIC of vancomycin as 
low as 4 mg/L. However, over 88% of the VRE with vanB variant in 
Swedish healthcare during 2009 had MIC of vancomycin of at least 16 
mg/L
1. Thus, it is unlikely that VRE of the vanB type was consistently 
missed. 
3.2.2  Prepreparation of samples 
Depending on the sample and study, the handling of the samples before 
culture on Slanetz–Bartley agar has varied. 
For caecal samples, the first step has always (i.e. in Paper I, III and IV) 
been to suspend approximately 0.5 grams of faecal material in 4.5 mL of 
saline. For the samples from 2000 to 2002 included in Paper I, the 
suspension was enriched before cultured on selective media. Thus, the faecal 
suspension was mixed with Enterococcosel broth containing vancomycin (8 
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mg/L final concentration) and incubated at 37°C for 24 hours. The samples 
in Paper I collected after 2002, as well as the samples in Paper III and IV 
were however not enriched but cultured directly on selective media. 
Environmental samples, i.e. socks and cloths, in both Paper III and IV 
were treated essentially the same way. Broth was added to the samples 
before they were placed in a stomacher and treated for one minute. Then, 
the wash fluid was (i) cultured directly on selective media and (ii) enriched 
before cultured on selective media. In Paper III, the broth used was 
Enterococcosel whereas in Paper IV buffered peptone water was used. The 
reason for not using Enterococcosel in Paper IV was that a more gentle 
treatment of the samples was desired as the samples were taken after 
disinfection and were anticipated to contain damaged but still viable 
bacteria. 
3.3  Species identification 
Potential VRE on selective media in Paper I, III and IV were first 
subcultured on horse blood agar and then on Bile-Esculine agar. If 
morphological appearance also on these media indicated that the isolates 
were enterococci, all (Paper I) or a subset (Paper III and IV) were identified 
to species level by fermentation of various sugars, e.g. arabinose, manitol, 
ribose, sacarose and sorbitol (Devriese et al., 1993). The species 
identification of selected isolates were confirmed using PCR (Dutka-Malen 
et al., 1995). For quality control, either of the reference strains E. faecalis 
ATCC 29212 or 33186 was used. 
3.4  Antimicrobial susceptibility testing 
All antimicrobial susceptibility testing (Paper I-IV) was performed by 
determining of MIC with a microdilution method using cation-adjusted 
Mueller–Hinton broth according to the standards of the CLSI (2008). Tests 
were performed in VetMIC
TM E-cocci panels produced by the National 
Veterinary Institute and the same reference strains as for species 
identification were used for quality control. 
Obtained MIC values were interpreted according to epidemiological cut-
off values issued by EUCAST (2011).   26
3.5  Molecular typing methods 
3.5.1  Polymerase chain reaction 
Polymerase chain reaction (PCR) was used to investigate the presence of 
various genes in three of the papers included in this thesis. 
In Paper I and II, PCR was used for confirmation of the vanA resistance 
genotype in the VRE (Dutka-Malen et al., 1995). In addition, the Tn1546 
transposon in which the genes responsible for the vancomycin resistance are 
located was typed using ten different PCRs amplifying the whole transposon 
(Woodford et al., 1998). Lastly, PCR was also used in Paper II to look for 
two different plasmid addiction systems and six enterococcal plasmid 
replicon types (Jensen et al., 2010; Rosvoll et al., 2010; Sletvold et al., 2008). 
3.5.2  Multilocus sequence typing 
Multilocus sequence typing (MLST) is a typing scheme used in Paper I-III 
to investigate the genetic relationship among VRE isolates. 
In MLST, a number of housekeeping genes (seven for E. faecium) are 
amplified with PCR, sequenced and then compared to previously known 
sequences of the genes (Homan et al., 2002). Based on the nucleotide 
sequences, each gene is assigned an allele number and the generated seven 
digit code is interpreted to a sequence type (ST). 
In Paper I and II, MLST was used since it is a typing method especially 
useful when strains isolated over long time periods are investigated (Homan 
et al., 2002; Enright & Spratt, 1999). Furthermore, the possibility for 
comparison of the variants of VRE identified among Swedish broilers to 
isolates of enterococci from other parts of the world also contributed to the 
choice of MLST as typing method in those two studies. 
However, in Paper III the aim for the molecular typing was to confirm 
that it was indeed the clone dominating among Swedish broilers that was 
persisting. This could have been done with several other methods (e.g. 
RAPD-PCR, PFGE, MLVA). But then the variation among isolates of the 
dominating clone for the alternative method would first need to be 
established. Hence, MLST was chosen in order to avoid that extra work. 
3.5.3  Pulsed-field Gel Electrophoresis 
In Paper II, mating experiments was performed to assess the transferability of 
vancomycin resistance. The isolates obtained could either be tranconjugants, 
i.e. originating from the recipient strain that had received the vanA gene, or 
mutants, i.e. originating from the donor strains that had become resistant to 
rifampicin and fusidic acid. To confirm that they did indeed originate from   27 
the recipient strain a typing method with high discriminatory ability was 
desirable. Therefore pulsed-field gel electrophoresis (PFGE) with SmaI as 
restriction enzyme was chosen. 
When performing PFGE, bacteria are incorporated in agarose gel plugs 
and lysed before the DNA is digested with restriction enzymes cleaving at 
specific, and preferably rare, nucleotide sequences. The resulting DNA 
fragments are then separated in a gel by applying an electrical current 
switching between two different directions with an angel of, for example, 
120°. Finally, the bands are visualised by staining and the band patterns are 
analysed (van Belkum et al., 2007; Sambrook & Russell, 2001). 
For epidemiological typing of VRE, PFGE has been considered as the 
“gold standard” (Homan et al., 2002). However, in some situations it can be 
too discriminatory and isolates that are actually the same strain can differ 
from each other with several bands (Morrison et al., 1999). 
In Paper II, a variation of PFGE designed to detect and determine the 
size of plasmids was used. Instead of digesting the DNA with a restriction 
enzyme it was treated with S1 nuclease. The S1 nuclease converts the 
circular or supercoiled three dimensional structures of plasmids into full 
length linear molecules (Barton et al., 1995). When separated on a gel, 
instead of three possible bands one plasmid then results in only one band. 
3.6  Filter mating 
To assess the possibility that vancomycin resistance will spread from VRE in 
Swedish broilers to other enterococci a number of isolates were subjected to 
mating experiment as a part of Paper II. 
In mating experiments the potential donor strain and the recipient are 
mixed and cultured together before screening for transconjugants, i.e. 
recipient strains that have become resistant to the antimicrobial of interest. 
Mating experiments can be performed either as filter or broth mating. For 
filter mating, broth cultures of the donor and recipient strains are mixed, 
added to a filter and cultured over night on blood agar. Then, the bacteria 
are suspended and cultured on media selecting for transconjugants. The 
difference in broth mating compared to filter mating is that the strains are 
mixed and kept in broth when incubated over night (Toomey et al., 2009) 
In Paper II, filter mating was done and performed as described by 
Hammerum et al. (1998) and with E. faecium 64/3 as recipient. Since E. 
faecium 64/3 is resistant to rifampicin and fusidic acid and the resistance of 
interest in this case was vancomycin resistance, the agar plates used for 
screening for transconjugants contained all these three antimicrobials.   28
3.7  Fitness studies 
In Paper IV, the ability of three VRE from Swedish broilers to survive 
and/or grow in various physical conditions was investigated. Assessed 
parameters were growth at different pH and temperatures, survival at 
different temperatures, tolerance to high temperatures and susceptibility to 
disinfectants. 
To investigate growth at different pH and temperatures, bacteria were 
inoculated in Mueller-Hinton broth (normal or with adjusted pH) and 
incubated (at test temperature or 37°C) before growth was determined as 
visible turbidity. 
To investigate survival at different temperatures, bacteria were pipetted 
into empty Petri dishes and allowed to dry. After various times of storage at 
6, 21.5 or 31°C, the number of surviving bacteria was determined by 
dissolving them in saline, pouring on agar and incubating over night. 
To investigate tolerance to high temperatures, bacteria were inoculated 
in pre-heated Mueller-Hinton broth and incubated for four hours at test 
temperature, cooled and incubated over night before growth was 
determined as visible turbidity. 
To investigate the susceptibility to disinfectants, a quantitative suspension 
test was used for the liquid agents (Reybrouck, 2004). Whereas for the 
gaseous agent, bacteria were pipetted into empty Petri dishes and allowed to 
dry and exposed to the agent before the number of surviving bacteria was 
compared to the number in unexposed dishes. 
3.8  Field disinfection experiment 
In Paper IV, a disinfection method that combines steam and formaldehyde 
was evaluated. Both the effect on occurrence of VRE in the broiler houses 
and on colonization of the birds sent for slaughter was investigated. 
The method was originally developed to sanitize layer hen farms from 
salmonellae but its efficacy towards enterococci had been shown under both 
laboratory and field conditions (Gradel et al., 2004a; Gradel et al., 2004b). 
3.9  Statistical analysis 
Statistical analyses were used in Paper I and III to investigate significant 
changes and associations. Since the data in both Paper I and III are mainly 
descriptive, only basic analyses, i.e. Pearson’s χ
2 test, were performed. All 
statistical work was done using Stata software (release 10, Stata, College 
Station, TX, USA).     29 
4  Results and Discussion 
The extensive use of avoparcin for growth promotion in farm animals can 
be seen as a full scale experiment of survival of the fit. Furthermore, the 
long term impact of the selection for VRE among farm animals is illustrated 
by the predicted persistence for at least forty years in Danish broiler 
production after the removal of the selective pressure exerted by avoparcin 
(Johnsen et al., 2011). 
4.1  Emergence of VRE 
In Sweden an increased occurrence of VRE among broilers was observed 
between 2000 and 2005 within the SVARM programme (Figure 5). All 
isolates are E. faecium with high level vancomycin resistance and all isolates 
where the resistance genotype has been investigated carry the vanA gene. 
The increase in VRE occurrence in Sweden is peculiar in that it 
appeared in the absence of any obvious selective pressure. The use of 
avoparcin in Sweden was discontinued about 15 years earlier (Wierup et al., 
1987). Moreover, all use of antimicrobial growth promoters to farm animals 
was forbidden in 1986 (SFS 1985:295). Today antimicrobials are seldomly 
used for treatment of bacterial diseases but ionophores, mainly narasin, are 
regularly used for coccidial prophylaxis. 
Apart from the increased occurrence in the apparent absence of selective 
pressure, also other findings indicated that the situation was peculiar. The 
majority of the isolates have identical resistance patterns with low level 
resistance to erythromycin and decreased susceptibility to narasin in addition 
to vancomycin resistance. This indicated that isolates were clonally related, 
which was further strengthened by investigations regarding phenotypical 
characteristics (Franklin et al., 2005).   30
In order to confirm the clonality, VRE isolates were typed with 
molecular methods (i.e. MLST) in Paper I. The typing confirmed that the 
increased occurrence was caused by the spread of one clone of E. faecium. 
The clone was of the vanA genotype, belonged to ST310 and had the 
prototype Tn1546 transposon of E. faecium BM4147. Such a predominance 
of one clone is in contrast with the situation in most other countries, where 
several different clones of VRE are isolated (Lim et al., 2006; Garcia-Migura 
et al., 2005; Novais et al., 2005; Borgen et al., 2002; Heuer et al., 2002b). 
 
Figure 5. Proportion of Swedish broilers colonized with VRE from 2000 to 2010. 
Whiskers indicate 95% confidence intervals. Data from the SVARM programme. 
The presence of VRE isolates with other resistance patterns among Swedish 
broilers was taken as an indication that these isolates belong to other clones. 
This was confirmed in Paper II where molecular typing revealed several 
different sequence types (STs). Moreover, a further analysed subset of 
isolates also differed in their SmaI PFGE digestion patterns. Compared to 
other countries, the situation in Sweden is special in that one clone is 
predominant and the others are in clear minority. 
Additional molecular characterization of the predominant and the 
minority clones was done in Paper II. These investigations showed that in 
all of the clones the vanA gene was plasmid mediated, and all but one had 
the prototype variant of the Tn1546 transposon. Both the plasmid 
localization of the vanA gene and the fact that the prototype variant of the 
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Tn1546 transposon was the most common are in agreement with previous 
knowledge about VRE of the vanA type (Biavasco et al., 2007; Courvalin, 
2006; Woodford et al., 1998). 
The number of plasmids detected in the different clones varied from one 
to four. Furthermore, the only plasmid replicon type detected among the 
clones was pRE25, although in five of the eleven clones none of the 
investigated plasmid replicon types was detected. In addition, under the 
investigated conditions vancomycin resistance was transferrable from six of 
the eleven clones. However, there does not seem to be any correlation 
between the varying traits, e.g. presence of pRE25 is not correlated to 
transfer of vancomycin resistance. 
All together, the molecular characterization of the different clones does 
not explain why one clone of VRE is predominant in Swedish broiler 
production. 
4.2  Spread of VRE 
The rapid increase in VRE occurrence from 2000 to 2005 and the 
predominance of one clone indicate that VRE did not emerge among 
Swedish broilers during the years when avoparcin was used. If that had been 
the case, one clone would probably not be predominant. Also, VRE would 
probably have been isolated in studies performed in the middle of the 1990’s 
(Quednau et al., 1998; Anonymous, 1997a). Instead, an introduction of 
VRE to Swedish broilers after the use of avoparcin had been discontinued is 
a more plausible scenario. This probably happened by the end of the 1990’s 
since the first isolate was found in 1998 (Kuhn et al., 2005). 
Regardless of whether VRE was introduced into, or less likely arose 
within the Swedish broiler production, once there, VRE spread to more 
and more farms. In 2002–2003, 18% of the farms were positive for VRE in 
faecal droppings collected about two weeks prior to slaughter (unpublished 
results). When a similar study was done in 2011, 27% of the farms were 
positive (unpublished results). Notably, the occurrence of VRE appears to 
have peaked in 2005. Since then, the proportion of broilers colonized with 
VRE has decreased and varied between 20 and 30% (Figure 5) (SVARM, 
2011). 
There are several ways by which both an introduction of VRE into the 
Swedish broiler production and the subsequent spread to more and more 
farms could have occurred. One source could be poultry feed or feedstuff 
where the presence of VRE has been described (Martins da Costa et al.,   32
2007). Contrary, VRE have never been isolated from broiler feed in 
Sweden (Nilsson et al., 2008 and unpublished results). 
Another way for introduction and spread of VRE could be via import of 
grandparent birds and a subsequent vertical spread within the broiler 
pyramid (see Figure 2, page 11). Spread with day old chickens have been 
described for various resistant bacteria, e.g. fluoroquinolone resistant 
Campylobacter coli and E. coli resistant to ampicillin and nalidixic acid 
(Bortolaia et al., 2010; Idris et al., 2006). Also indications of the presence of 
VRE in day old chickens have been reported (Garcia-Migura et al., 2007). 
On the other hand, VRE was not isolated at Norwegian hatcheries when 
sampled four years after the use of avoparcin was discontinued in Norway 
(Borgen et al., 2000b). Furthermore, VRE have never been isolated at 
hatcheries in Sweden (Nilsson et al., 2008 and unpublished results). Notable 
though is that VRE of the same type as the clone dominating among 
broilers in Sweden was isolated from broilers in Norway in 1999 (Rosvoll et 
al., 2010). This could indicate that there has been a vertical spread within 
the broiler pyramid since there has been trade with birds between the 
countries, mainly export of parent birds from Sweden to Norway. 
In summary, the studies performed in Sweden show that there is no 
continuous introduction of VRE, neither by feed nor by day old chickens 
into Swedish broiler production. Nevertheless, these routes could still have 
been the original source(s) of introduction. 
Another possible vehicle for the spread between farms is trucks used for 
collecting and loading birds for slaughter. These trucks are affiliated with the 
respective slaughterhouses and are used at all farms associated to the 
respective slaughterhouses. In a small study, VRE was found in five out of 
six samples taken from two different trucks as they were ready to leave the 
slaughterhouses to collect birds at production sites (Jansson et al., 2009b). 
These findings indicate that also other equipment used when collecting birds 
for slaughter could be contaminated with, and introduce VRE into a broiler 
house, as described for other bacteria (Slader et al., 2002; Mead et al., 1994). 
Still, once the birds have been slaughtered, the compartments are cleaned 
and disinfected and an introduction of VRE with these trucks and related 
equipment should therefore theoretically be eliminated directly. However, if 
an all-in all-out procedure is not strictly practiced there is a potential for 
proliferation of VRE in the remaining birds before the compartments are 
emptied and can be cleaned and disinfected. Previously, so called thinning, 
where a proportion of the broilers within a compartment are slaughtered 
about one week before the remaining birds, was practiced in Swedish   33 
broiler production. Thinning was however associated with increased 
likelihood for isolating campylobacter from the broiler flocks (Hansson et al., 
2004) and it is therefore no longer practiced. But birds in one compartment 
are still, due to slaughterhouse capacity, sometimes slaughtered on two 
consecutive days, or exceptionally with a week-end in between. Also such 
“split slaughter” could potentially lead to proliferation of VRE, although to 
a lesser extent than if thinning is practiced. 
4.3  Persistence of VRE 
Persistence of VRE in the broiler houses between batches was seen in Paper 
III and IV, as well as in a study related to this thesis (Jansson et al., 2009b). 
That VRE persists in the broiler houses is an important aspect of the 
epidemiology which has also been described in previous studies (Garcia-
Migura et al., 2007; Heuer et al., 2002b; Borgen et al., 2000b). In addition, 
in one of the farms sampled in Paper III, VRE could be isolated from all 
environmental samples from cleaned and disinfected compartments. This 
shows how widespread VRE can be within the broiler houses. 
Differences among farms with regard to the degree of environmental 
VRE contamination were shown in Paper III. These differences were also 
reflected in the proportion of birds colonized with VRE at slaughter. 
Variations in contamination and colonization could be due to differences in 
management routines among the farms but this was not investigated in 
Paper III. A study looking at management routines at Swedish broiler farms 
with or without VRE was done previously but no consistent differences 
were identified (Jansson et al., 2009b). Nevertheless, the differences among 
farms demonstrated in Paper III indicate the possibility to influence the 
degree of environmental VRE contamination. If the factor(s) causing these 
differences were identified, it would be possible to reduce the occurrence of 
VRE within the broiler houses. This would then lead to a decrease in the 
proportion of broilers colonized with VRE. 
Another aspect of persistence of VRE is the fact that the enterococci retain 
the vancomycin resistance. Elsewhere, linkage to plasmid addiction systems 
as well as co-selection by the use of other antimicrobials has been suggested 
as reasons for the persistence of the vanA gene among enterococci (Johnsen 
et al., 2005; Aarestrup, 2000). 
In VRE isolated from broilers in Norway, the vanA gene has been 
shown to be located on the same plasmid as the ω-ε-ζ plasmid addiction 
system (Johnsen et al., 2005). In a VRE of animal origin from Italy was both   34
the  ω-ε-ζ and the axe-txe systems detected (Rosvoll et al., 2010). The 
presence of these plasmid addiction systems among the different clones of 
VRE in Swedish broiler production was investigated in Paper II. 
The  ω-ε-ζ system was detected only in one of the minority clones 
whereas the axe-txe system was not detected in any of the clones. This 
indicates that plasmid addiction systems do not play as an important role in 
the persistence of VRE in Swedish broiler production as the ω-ε-ζ system 
has been suggested to do in Norwegian broiler production (Johnsen et al., 
2005). This was also indicated by the fact that in the clone were the ω-ε-ζ 
system was present it did not seem to be closely linked to the vanA gene, as 
the genes were not co-transferred in the conjugation assay in Paper II. 
A coincidental finding of the conjugation assay in Paper II was that in 
four of the six clones with transferrable vancomycin resistance, decreased 
susceptibility to narasin was co-transferred. The ionophore narasin is widely 
used narasin for coccidial prophylaxis and decreased susceptibility is 
common among both vancomycin susceptible E. faecium as well as VRE 
from Swedish broilers. Therefore co-selection of VRE by the use of narasin 
is unlikely. Neither the mechanism of decreased susceptibility to narasin, nor 
its connection to the vancomycin resistance has been investigated but the 
genes involved could for example be located close to each other. Thereby 
the use of narasin could actually play a role in the persistence of the vanA 
gene among enterococci in Swedish broilers. 
4.4  Potential for zoonotic spread 
One negative implication of the presence of VRE in farm animals is the 
potential for zoonotic spread via the food chain. VRE contamination of 
animal derived food products reaching consumers was shown at the time 
when avoparcin was still used (van den Braak et al., 1998; Klare et al., 
1995a). In Sweden, VRE was isolated from 36% of imported and 14% of 
domestically produced chicken fillets sampled in a pilot study preceding this 
thesis (unpublished results). 
The implication of VRE present on broiler meat depends partly on 
whether the VRE has transferrable vancomycin resistance or not. A broiler 
adapted enterococcus will only transiently stay in humans and it is also less 
likely than hospital adapted enterococci to cause disease (Sorensen et al., 
2001; Willems et al., 2000; Berchieri, 1999). Nevertheless, it has been 
demonstrated that the vanA gene can be transferred from VRE of animal 
origin to human enterococci in the intestines of humans (Lester et al., 2006).   35 
To investigate if VRE from Swedish broilers can transfer their 
vancomycin resistance, a conjugation assay with representatives of both the 
predominant and the minority clones of VRE was performed in Paper II. 
Under the investigated conditions, the vanA gene was transferrable from 
both the dominating and five of the ten minority clones. The vanA gene is 
commonly transferrable (French, 1998), thus it was expected that the 
vancomycin resistance would be transferrable from all the investigated 
clones. It is possible that the vancomycin resistance is transferrable also from 
the remaining clones if the experimental conditions, e.g. temperature and 
recipient, are altered. 
Nevertheless, the majority of VRE from Swedish broilers belongs to one 
predominant clone and the ability of that clone to transfer vancomycin 
resistance is proven (Paper I and II). But when assessing the potential for 
zoonotic spread of vancomycin resistance from Swedish broilers, it is also 
important to remember that VRE only constitutes a minute proportion of 
all enterococci in the intestine of a broiler. This is demonstrated by the fact 
that only 4 VRE have been found among 1666 randomly selected 
enterococci from broilers (out of which 1040 are E. faecium) investigated 
within the SVARM programme since 2000 (SVARM, 2011). 
In accordance, the presence of VRE among Swedish broilers does not 
seem to have affected the situation in Swedish healthcare where there is a 
predominance of VRE isolates with the vanB gene (SWEDRES, 2010). 
Nonetheless, the presence of VRE in Swedish broiler production constitutes 
a reservoir of vanomycin resistance that is unwanted and if possible should 
be eliminated. 
4.5  Ways to reduce the occurrence of VRE 
The results of Paper II confirm that VRE among Swedish broiler have the 
potential for zoonotic spread of vancomycin resistance genes. Furthermore, 
the absence of a continuous introduction of VRE to Swedish broiler 
production together with the results of Paper III indicates that the 
occurrence of VRE could be reduced. Possibly, VRE might even be 
eliminated from Swedish broiler production – an approach that has probably 
never been attempted elsewhere before. 
Currently, birds are colonized by VRE persisting in the broiler houses. 
This leads to proliferation of VRE and an increase in the contamination, 
apparently to such an extent that the cleaning and disinfection does not 
manage to eliminate the contamination. Contrary, a reduced contamination 
of the broiler houses would lead to fewer colonized birds and subsequently   36
to a reduction in the contamination of the broiler houses. The intervention 
could be at two points: hindering the birds from becoming colonized with 
VRE and reducing the number of VRE that can potentially colonize the 
birds. 
Competitive exclusion with probiotics has been used to prevent intestinal 
colonization of various bacteria in both human and veterinary medicine. 
Promising results have been reported regarding reduction of VRE 
colonization of broilers (Sakai et al., 2006) but studies regarding the effect of 
probiotics on intestinal VRE colonization in humans have been 
discouraging (de Regt et al., 2010; Vidal et al., 2010). Furthermore, futile 
experiments on use of probiotics to protect broilers from being colonized 
with VRE have been done in work related to this thesis (Jansson et al., 
2009a). Due to these discouraging findings it was considered unlikely that 
occurrence of VRE among Swedish broilers could be reduced by the means 
of competitive exclusion. 
A reduction in the number of VRE that can colonize the broilers is 
obviously achieved by the normal cleaning and disinfection routines 
practiced between batches, as they for example include removing all the 
litter from the broiler houses. However, the findings in Paper III and IV 
show that VRE persist in the houses. There can be various reasons why the 
VRE persist. One explanation could be that VRE among Swedish broilers, 
and especially the predominant clone, have a reduced susceptibility to the 
commonly used disinfectants. Decreased susceptibility to disinfectants is 
known to occur among various bacteria and has also been described in 
association with antimicrobial resistance (Cerf et al., 2010; SCENHIR, 
2009; EFSA, 2008a). 
In Paper IV, the ability of three VRE isolates from Swedish broilers to 
sustain various physical conditions including exposure to commonly used 
disinfectants was investigated. The disinfectants were found to be fully 
effective at recommended concentrations of the products. This, together 
with the fact that no differences in the stated management routines could be 
detected between VRE positive or negative farms (Jansson et al., 2009b), 
implies that the problem lies within difficulties to fulfill the disinfection 
protocols. The explanation could be problems to (i) adequately clean the 
broiler houses before disinfection and/or (ii) apply the disinfectant into all 
equipment and at all locations in the houses. Thus, a disinfection protocol 
that circumvents these problems is needed. 
In Paper IV, a pilot study was performed to evaluate the possibility to 
eliminate VRE with a disinfection method that combines steam and   37 
formaldehyde. The method was originally developed to sanitize layer hen 
farms from salmonellae (Gradel et al., 2004a). 
Although the disinfection experiment was only performed at two farms, 
the results show that the tested method was more efficient in reducing the 
environmental VRE contamination than the normal routines on these 
farms. The predicted reduction in colonization of the birds was however not 
conclusive. Nevertheless, the results indicate a possibility to reduce the 
occurrence of VRE in Swedish broiler production. 
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5  Conclusions 
This work demonstrates that the occurrence of VRE in Swedish broiler 
production can probably be reduced. The project has also generated deeper 
understanding about the epidemiology of VRE among Swedish broilers. 
The specific conclusions of the project are: 
 The increase in proportion of broilers colonized with VRE from 
2000 to 2005 was caused by the spread of one clone which still 
persists and is predominant among VRE from Swedish broilers. 
 Several clones of VRE have been isolated from Swedish broilers but 
one clone is predominant. 
 All the clones are E. faecium with plasmid mediated vanA gene. 
 The vanA gene is transferrable from the predominant as well as from 
several of the minority clones. This shows that VRE among Swedish 
broilers have a potential for zoonotic spread of the resistance genes. 
 There is a near absence of the investigated plasmid addiction systems, 
indicating that such systems are not responsible for retaining the vanA 
gene among enterococci in Swedish broiler production. 
 Decreased susceptibility to narasin can be co-transferred with the 
vanA gene. This indicates that the traits are linked and that the use of 
narasin might contribute to the persistence of vancomycin resistance 
among enterococci in Swedish broiler production. 
 Broilers are colonized with VRE persisting in the broiler houses 
between batches of birds. However, variations among farms in degree 
of contamination of houses as well as in proportion of colonized birds 
indicate that the occurrence of VRE can be reduced. 
 The VRE contamination of the broiler houses can be reduced by 
disinfection with a method combining steam and formaldehyde. This 
method could be useful to eliminate VRE persisting at farms. 
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6  Perspectives for the future 
The persistence, spread and increased occurrence of one clone of VRE, 
apparently without selective pressure within the Swedish broiler production 
shows how complex and unpredictable the epidemiology of antimicrobial 
resistance can be. It also shows that no matter when and where 
antimicrobials are used without caution, it can have implications on 
resistance both geographically and temporally remote. 
Even though VRE with transferrable vancomycin resistance are present in 
Swedish broiler production, the situation in Swedish healthcare does not 
seem to have been affected. Nevertheless, VRE among Swedish broilers 
constitute a reservoir of resistance genes that, if possible should be 
eliminated. 
Elimination of VRE from the Swedish broiler production could possibly be 
achieved by reducing persistence in the broiler houses with adequate 
cleaning and disinfection. Ways to investigate this could include large scale 
disinfection studies where all of the houses at farms are disinfected. 
Also the role of narasin in the persistence of the vancomycin resistance in 
enterococci in Swedish broilers needs to be further studied. Possibly, the use 
of narasin acts as a sort of plamid addiction system and ensures stable 
inheritance of the vanA gene. Objectives for the future would include 
clarifying the genetic background and mechanism of the decreased 
susceptibility to narasin as well as its linkage to the vanA gene. 
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7  Populärvetenskaplig sammanfattning 
7.1  Introduktion 
Vankomycinresistenta enterokocker (VRE) är ett samlingsord för många 
olika kombinationer av enterokocker och gener. Den vanligaste varianten är 
Enterococcus faecium med vanA som den gen som kodar för resistens mot 
vankomycin. Men bland människor i Sverige är E. faecium med vanB 
vanligast. VRE är en viktig orsak till sjukhusassocierade infektioner men att 
bara bära bakterierna i tarmen är mycket vanligare än att bli sjuk och få 
kliniska symptom. 
VRE finns också hos livsmedelsproducerande djur. Det beror på att 
antibiotikumet avoparcin i många Europeiska länder använts i stor 
omfattning för att öka djurens tillväxt. Både avoparcin och vankomycin är 
antibiotika i gruppen glykopeptider. Likheten mellan molekylerna ger 
korsresistens, det vill säga resistens mot den ena substansen innebär resistens 
också mot den andra. 
När det blev känt att VRE var vanligt hos livsmedelsproducerande djur i 
Europa förbjöds avoparcin. Detta skedde först i Danmark, Norge och 
Finland, sedan i Tyskland och slutligen, 1997, i hela EU efter ett beslut i EU 
kommissionen (Kommissionsdirektiv 97/6/EC). 
Förbudet i Europa mot att använda avoparcin berodde på en oro för att 
VRE skulle sprida sig från djur till människor via livsmedel (Figur 1, sidan 
10). De gener som ger vankomycinresistens kan nämligen föras över från 
enterokocker hos djur till enterokocker anpassade till människor och göra att 
människor under längre tid bär på VRE. Om antalet friska människor som 
bär på VRE ökar skulle även antalet infektioner med VRE i sjukvården 
kunna öka. Sedan avoparcin förbjöds har förekomsten av VRE bland 
livsmedelsproducerande djur minskat.   44
I Sverige användes avoparcin endast från mitten av 1970-talet till 1984. 
Dessutom är det sedan 1986 förbjudet att över huvud taget använda 
antibiotika för att öka djurs tillväxt. Därmed har enterokocker hos 
livsmedelsproducerande djur i Sverige inte på samma sätt som i övriga 
Europa haft någon fördel av att vara vankomycinresistenta. I mitten på 
1990-talet, när förekomsten av VRE hos livsmedelsproducerande djur i 
Europa var som högst, hittades inte heller VRE i Sverige. 
Först 1998 isolerades VRE från livsmedelsproducerande djur i Sverige. 
Efter det upptäcktes i resistensövervakningsprogrammet SVARM (Svensk 
Veterinär Antibiotika Resistens Monitorering) en tydlig ökning i andelen 
slaktkycklingar med VRE i tarmen (Figur 5, sidan 30). Ökningen var 
oväntad eftersom det inte fanns något som uppenbart gynnade VRE framför 
enterokocker känsliga för vankomycin. Dessutom verkade det som att 
ökningen berodde på spridning av en enda klon av VRE eftersom nästan alla 
isolat var känsliga för, respektive resistenta mot samma antibiotika. 
Trots att andelen slaktkycklingar som bär på VRE ökat är det bara en 
liten del av alla enterokocker i tarmen hos en slaktkyckling som är VRE. 
Sedan 2000 har bara 4 VRE hittats bland 1666 slumpmässigt utvalda 
enterokocker från slaktkyckling som undersökts i SVARM. Ökningen av 
VRE upptäcktes bara för att prover odlades så att enbart VRE kunde växa. 
7.2  Sammanfattning av avhandlingsarbetet 
Målet för avhandlingsarbetet var att undersöka varför förekomsten av VRE i 
svensk slaktkycklingproduktion ökade i början av 2000-talet samt om 
förekomsten kan minskas. 
Arbetet har visat att ökningen av VRE beror på att en klon av E. faecium 
av typen ST310 har spridit sig i svensk slaktkycklingproduktion (Artikel 1 
och 2). Även andra kloner finns i svensk slaktkycklingproduktion men alla är 
E. faecium med vanA som den gen som ger vankomycinresistens (Artikel 1 
och 2). I alla kloner sitter genen på en plasmid, det vill säga en cirkelformad, 
ofta rörlig, bit arvsmassa (Artikel 2). 
Både från den dominerande och från flera av de övriga klonerna kunde 
generna som är inblandade i vankomycinresistensen föras över till andra 
enterokocker (Artikel 2). Därmed är inte oförmåga att föra över generna 
förklaringen till varför en klon dominerar bland VRE hos svensk 
slaktkyckling. Men det betyder att VRE bland svensk slaktkyckling är en 
reservoar för resistensgener som kan sprida sig till enterokocker anpassade till 
människor.   45 
Trots att avoparcin sedan länge inte används finns genen för 
vankomycinresistens kvar bland enterokocker hos slaktkycklingar, både i 
Sverige och i övriga Europa. En förklaring skulle kunna vara att generna är 
kopplade till ”plasmid addiction system”. Sådana system är en kombination 
av ett toxin och ett antitoxin där toxinet bryts ner långsammare än 
antitoxinet. Om bakterien som har systemet gör sig av med det kommer 
toxinet fortfarande att finnas kvar när antitoxinet försvunnit. Bakterien 
kommer då att dödas av toxinet den själv har bildat. Detta gör att bakterien 
måste behålla den plasmid som systemet sitter på och därmed även andra 
gener på samma plasmid. Men sådana system verkar inte finnas i någon 
större grad bland VRE i svensk slaktkycklingproduktion (Artikel 2). 
Ionoforer, som narasin, används i nästan all slaktkycklingproduktion för 
att förebygga tarminfektioner med koccidier. Minskad känslighet för narasin 
kan föras över till andra enterokocker tillsammans med resistens mot 
vankomycin (Artikel 2). Att de förs över samtidigt beror troligen på att de 
kodande generna sitter nära varandra i enterokockernas arvsmassa. Därmed 
skulle alltså användningen av narasin inte bara göra så att den minskade 
känsligheten för narasin utan även resistensen mot vankomycin blir kvar i 
enterokockerna. 
Att VRE kan finnas kvar i slaktkycklinghusen mellan uppfödningsomgångar 
trots rengöring och desinficering är känt sedan tidigare och visades även i 
avhandlingsarbetet (Artikel 3 och 4). Mängden VRE i husen ökar under en 
omgång slaktkycklingar för att sedan minska när husen rengörs och 
desinficeras efter att kycklingarna slaktats (Artikel 3). 
Mängden VRE som finns kvar i slaktkycklinghusen skiljer sig mellan 
olika gårdar och det avspeglas i andelen kycklingar med VRE (Artikel 3). 
Att det finns skillnaderna mellan olika gårdar tyder på att mängden VRE på 
gårdarna kan påverkas och att förekomsten i svensk slaktkycklingproduktion 
skulle kunna minskas med rätt åtgärder. 
Att VRE finns kvar efter rengöring och desinficering beror inte på att de 
är okänsliga för de desinficeringsämnen som oftast används inom svensk 
slaktkycklingproduktion (Artikel 4). Anledningen är istället troligtvis 
svårigheter i att lyckas med rengöringen och desinficeringen. Problemet kan 
till exempel vara att lyckas avlägsna all smuts från sprickor och utrustning 
samt att få tillräcklig mycket desinficeringsämnena under tillräckligt lång tid 
till alla delar av husen. 
För att om möjligt lösa problemet med rengöring och desinficering av 
husen testades i ett fältförsök en desinficeringsmetod som kombinerar hög 
temperatur från vattenånga med formalin (Artikel 4). Den testade metoden   46
minskade mängden VRE i slaktkycklinghusen mer än de metoder som 
normalt användes på gårdarna. Detta betyder att det borde gå att minska 
förekomsten av VRE i svensk slaktkycklingproduktion i stort och att det 
kanske till och med går att helt få bort dem. 
7.3  Konklusion och betydelse för framtiden 
Avhandlingsarbetet har ökat kunskapen om varför VRE finns i svensk 
slaktkycklingproduktion  och vad det eventuellt har för betydelse för 
människors hälsa. Dessutom har arbetet gett uppslag till hur förekomsten av 
VRE kan minskas. 
Att förekomsten av VRE har ökat beror på att en klon spridit sig i svensk 
slaktkycklingproduktion. Det finns även andra kloner men de utgör bara en 
liten andel av alla VRE. Både den klon som dominerar och de övriga är E. 
faecium med vanA som den gen som ger vankomycinresistens. I alla klonerna 
sitter vanA genen på en plasmid. 
Både från den dominerande klonen och från flera av de övriga kan genen 
för vankomycinresistensen föras över till andra enterokocker. Detta betyder 
att VRE i svensk slaktkycklingproduktion är en reservoar för resistensgener 
som kan spridas och påverka människors hälsa. 
Att genen för vankomycinresistensen behålls av enterokocker i svensk 
slaktkycklingproduktion beror inte på att resistensen är kopplad till ”plasmid 
addiction systems”. Däremot verkar resistensen vara nära kopplad till 
minskad känslighet för ionoforen narasin vilken används för att förebygga 
tarminfektioner med koccidier. Därmed skulle alltså användningen av 
narasin inte bara göra så att den minskade känsligheten för narasin utan även 
resistensen mot vankomycin blir kvar i enterokockerna. 
De slaktkycklingar som kommer till gårdarna koloniseras troligen av 
VRE som finns kvar i slaktkycklinghusen sedan föregående 
uppfödningsomgång. Att det finns skillnader mellan gårdar i mängd VRE i 
husen tyder på att förekomsten kan minskas och detta antagande förstärks av 
resultaten från undersökningen med en ny desinficeringsmetod. 
Framtida forskning bör undersöka vilken roll användningen av narasin 
har för att enterokocker i svensk slaktkycklingproduktion behåller de gener 
som kodar för vankomycinresistens. Viktigt är också att ytterligare 
undersöka möjligheten att helt få bort VRE från slaktkycklinggårdar. 
    47 
References 
Aarestrup, F.M. (1995). Occurrence of glycopeptide resistance among Enterococcus faecium 
isolates from conventional and ecological poultry farms. Microb Drug Resist 1(3), 
255-7. 
Aarestrup, F.M. (2000). Characterization of glycopeptide-resistant enterococcus faecium 
(GRE) from broilers and pigs in Denmark: genetic evidence that persistence of 
GRE in pig herds is associated with coselection by resistance to macrolides. J Clin 
Microbiol 38(7), 2774-7. 
Aarestrup, F.M., Kruse, H., Tast, E., Hammerum, A.M. & Jensen, L.B. (2000). Associations 
between the use of antimicrobial agents for growth promotion and the occurrence 
of resistance among Enterococcus faecium from broilers and pigs in Denmark, 
Finland, and Norway. Microb Drug Resist 6(1), 63-70. 
Aarestrup, F.M., Seyfarth, A.M., Emborg, H.D., Pedersen, K., Hendriksen, R.S. & Bager, F. 
(2001). Effect of abolishment of the use of antimicrobial agents for growth 
promotion on occurrence of antimicrobial resistance in fecal enterococci from food 
animals in Denmark. Antimicrob Agents Chemother 45(7), 2054-9. 
Andersson, D.I. & Hughes, D. (2010). Antibiotic resistance and its cost: is it possible to 
reverse resistance? Nature reviews. Microbiology 8(4), 260-71. 
Andersson, D.I. & Levin, B.R. (1999). The biological cost of antibiotic resistance. Curr Opin 
Microbiol 2(5), 489-93. 
Anonymous (1997a). Antimicrobial Feed Additives; SOU 1997:132, Annex D. Stockholm, 
Sweden: Fritzes Bookshop. ISBN 91-38-20707-9. 
Anonymous (1997b). Commission directive 97/6/EC. Official journal of the European 
Communities L35 5.2.97, 11-13. 
Arthur, M., Reynolds, P.E., Depardieu, F., Evers, S., Dutka-Malen, S., Quintiliani, R., Jr. & 
Courvalin, P. (1996). Mechanisms of glycopeptide resistance in enterococci. J Infect 
32(1), 11-6. 
Bager, F., Madsen, M., Christensen, J. & Aarestrup, F.M. (1997). Avoparcin used as a growth 
promoter is associated with the occurrence of vancomycin-resistant Enterococcus 
faecium on Danish poultry and pig farms. Prev Vet Med 31(1-2), 95-112. 
Barnes, E.M. (1959). Differential and selective media for the faecal streptococci. J Sci Food 
Agric 10(12), 656-662.   48
Barton, B.M., Harding, G.P. & Zuccarelli, A.J. (1995). A general method for detecting and 
sizing large plasmids. Anal Biochem 226(2), 235-40. 
Bates, J. (1997). Epidemiology of vancomycin-resistant enterococci in the community and 
the relevance of farm animals to human infection. J Hosp Infect 37(2), 89-101. 
Bell, J.M., Paton, J.C. & Turnidge, J. (1998). Emergence of vancomycin-resistant 
enterococci in Australia: phenotypic and genotypic characteristics of isolates. J Clin 
Microbiol 36(8), 2187-90. 
Berchieri, A. (1999). Intestinal colonization of a human subject by vancomycin-resistant 
Enterococcus faecium. Clin Microbiol Infect 5(2), 97-100. 
Biavasco, F., Foglia, G., Paoletti, C., Zandri, G., Magi, G., Guaglianone, E., Sundsfjord, A., 
Pruzzo, C., Donelli, G. & Facinelli, B. (2007). VanA-type enterococci from 
humans, animals, and food: species distribution, population structure, Tn1546 
typing and location, and virulence determinants. Appl Environ Microbiol 73(10), 
3307-19. 
Bonten, M.J., Willems, R. & Weinstein, R.A. (2001). Vancomycin-resistant enterococci: 
why are they here, and where do they come from? Lancet Infect Dis 1(5), 314-25. 
Borgen, K., Simonsen, G.S., Sundsfjord, A., Wasteson, Y., Olsvik, O. & Kruse, H. (2000a). 
Continuing high prevalence of VanA-type vancomycin-resistant enterococci on 
Norwegian poultry farms three years after avoparcin was banned. J Appl Microbiol 
89(3), 478-85. 
Borgen, K., Sorum, M., Kruse, H. & Wasteson, Y. (2000b). Persistence of vancomycin-
resistant enterococci (VRE) on Norwegian broiler farms. FEMS Microbiol Lett 
191(2), 255-8. 
Borgen, K., Wasteson, Y., Kruse, H. & Willems, R.J. (2002). Vancomycin-resistant 
Enterococcus faecium (VREF) from Norwegian poultry cluster with VREF from 
poultry from the United Kingdom and The Netherlands in an amplified fragment 
length polymorphism genogroup. Appl Environ Microbiol 68(6), 3133-7. 
Bortolaia, V., Bisgaard, M. & Bojesen, A.M. (2010). Distribution and possible transmission of 
ampicillin- and nalidixic acid-resistant Escherichia coli within the broiler industry. 
Vet Microbiol 142(3-4), 379-86. 
Boyd, D.A., Willey, B.M., Fawcett, D., Gillani, N. & Mulvey, M.R. (2008). Molecular 
characterization of Enterococcus faecalis N06-0364 with low-level vancomycin 
resistance harboring a novel D-Ala-D-Ser gene cluster, vanL. Antimicrob Agents 
Chemother 52(7), 2667-72. 
Butaye, P., Devriese, L.A. & Haesebrouck, F. (2003). Antimicrobial growth promoters used 
in animal feed: effects of less well known antibiotics on gram-positive bacteria. Clin 
Microbiol Rev 16(2), 175-88. 
Cerf, O., Carpentier, B. & Sanders, P. (2010). Tests for determining in-use concentrations of 
antibiotics and disinfectants are based on entirely different concepts: "resistance" has 
different meanings. Int J Food Microbiol 136(3), 247-54. 
CLSI (2008). Performance Standards for Antimicrobial Disc and Dilution Susceptibility Tests for 
Bacteria Isoalted from Animals; Approved Standard - Third Edition. Wayne, PA: Clinical 
and Laboratory Standards Institute. CLSI document M31-A3.   49 
CLSI (2010). Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational 
Supplement. Wayne, PA: Clinical and Laboratory Standards Institute. CLSI 
document M100-S20. 
Courvalin, P. (2006). Vancomycin resistance in gram-positive cocci. Clin Infect Dis 42 Suppl 
1, S25-34. 
de Regt, M.J., Willems, R.J., Hene, R.J., Siersema, P.D., Verhaar, H.J., Hopmans, T.E. & 
Bonten, M.J. (2010). Effects of probiotics on acquisition and spread of 
multiresistant enterococci. Antimicrob Agents Chemother 54(7), 2801-5. 
Devriese, L.A., Hommez, J., Wijfels, R. & Haesebrouck, F. (1991). Composition of the 
enterococcal and streptococcal intestinal flora of poultry. J Appl Bacteriol 71(1), 46-
50. 
Devriese, L.A., Pot, B. & Collins, M.D. (1993). Phenotypic identification of the genus 
Enterococcus and differentiation of phylogenetically distinct enterococcal species 
and species groups. J Appl Bacteriol 75(5), 399-408. 
DiazGranados, C.A., Zimmer, S.M., Klein, M. & Jernigan, J.A. (2005). Comparison of 
mortality associated with vancomycin-resistant and vancomycin-susceptible 
enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis 41(3), 327-33. 
Donabedian, S.M., Perri, M.B., Abdujamilova, N., Gordoncillo, M.J., Naqvi, A., Reyes, 
K.C., Zervos, M.J. & Bartlett, P. (2010). Characterization of vancomycin-resistant 
Enterococcus faecium isolated from swine in three Michigan counties. J Clin 
Microbiol 48(11), 4156-60. 
Dutka-Malen, S., Evers, S. & Courvalin, P. (1995). Detection of glycopeptide resistance 
genotypes and identification to the species level of clinically relevant enterococci 
by PCR. J Clin Microbiol 33(1), 24-7. 
EFSA (2008a). Scientific opinion of the Panel on Biological Hazards on a request from DG 
SANCO on the assessment of the possible effect of the four antimicrobial 
treatment substances on the emergence of antimicrobial resistance. EFSA Journal 
659, 1-26. 
EFSA (2008b). Scientific Opinion of the Panel on Biological Hazards on a request from the 
European Food Safety Authority on foodborne antimicrobial resistance as a 
biological hazard. The EFSA Journal (765), 1-87. 
Enright, M.C. & Spratt, B.G. (1999). Multilocus sequence typing. Trends Microbiol 7(12), 
482-7. 
EUCAST EUCAST, Clinical Breakpoints. [online] Available from: 
http://www.srga.org/eucastwt/MICTAB/index.html. [Accessed 2011-02-21]. 
Euzeby, J.P. List of Prokaryotic names with Standing in Nomenclature - Genus Enterococcus. [online] 
Available from: http://www.bacterio.cict.fr/e/enterococcus.html. [Accessed 2011-
04-26]. 
Fisher, K. & Phillips, C. (2009). The ecology, epidemiology and virulence of Enterococcus. 
Microbiology 155(Pt 6), 1749-57. 
Franklin, A., Greko, C., Pringle, M., Kuhn, I., Rehbinder, V., Finn, M. & Bengtsson, B. 
Vancomycin-resistant enterococci (VRE) in Swedish broiler chickens. In: 
Proceedings of 2nd International ASM-FEMS Conference on Enterococci, Helsingör, 
Denmark, August 28-31, 2005 2005. p. 94.   50
Freitas, A.R., Coque, T.M., Novais, C., Hammerum, A.M., Lester, C.H., Zervos, M.J., 
Donabedian, S., Jensen, L.B., Francia, M.V., Baquero, F. & Peixe, L. (2011). 
Human and Swine Hosts Share Vancomycin-Resistant Enterococcus faecium 
CC17 and CC5 and Enterococcus faecalis CC2 Clonal Clusters Harboring Tn1546 
on Indistinguishable Plasmids. J Clin Microbiol 49(3), 925-31. 
French, G.L. (1998). Enterococci and vancomycin resistance. Clin Infect Dis 27 Suppl 1, S75-
83. 
Garbutt, J.M., Ventrapragada, M., Littenberg, B. & Mundy, L.M. (2000). Association 
between resistance to vancomycin and death in cases of Enterococcus faecium 
bacteremia. Clin Infect Dis 30(3), 466-72. 
Garcia-Migura, L., Liebana, E., Jensen, L.B., Barnes, S. & Pleydell, E. (2007). A longitudinal 
study to assess the persistence of vancomycin-resistant Enterococcus faecium 
(VREF) on an intensive broiler farm in the United Kingdom. FEMS Microbiol Lett 
275(2), 319-25. 
Garcia-Migura, L., Pleydell, E., Barnes, S., Davies, R.H. & Liebana, E. (2005). 
Characterization of vancomycin-resistant Enterococcus faecium isolates from 
broiler poultry and pig farms in England and Wales. J Clin Microbiol 43(7), 3283-9. 
Ghidan, A., Dobay, O., Kaszanyitzky, E.J., Samu, P., Amyes, S.G., Nagy, K. & Rozgonyi, 
F. (2008). Vancomycin resistant enterococci (VRE) still persist in slaughtered 
poultry in hungary 8 years after the ban on avoparcin. Acta Microbiol Immunol Hung 
55(4), 409-17. 
Giraffa, G. (2002). Enterococci from foods. FEMS Microbiol Rev 26(2), 163-71. 
Gradel, K.O., Jorgensen, J.C., Andersen, J.S. & Corry, J.E. (2004a). Monitoring the efficacy 
of steam and formaldehyde treatment of naturally Salmonella-infected layer houses. 
J Appl Microbiol 96(3), 613-22. 
Gradel, K.O., Sayers, A.R. & Davies, R.H. (2004b). Surface disinfection tests with 
Salmonella and a putative indicator bacterium, mimicking worst-case scenarios in 
poultry houses. Poult Sci 83(10), 1636-43. 
Hammerum, A.M., Jensen, L.B. & Aarestrup, F.M. (1998). Detection of the satA gene and 
transferability of virginiamycin resistance in Enterococcus faecium from food-
animals. FEMS Microbiol Lett 168(1), 145-51. 
Hammerum, A.M., Lester, C.H. & Heuer, O.E. (2010). Antimicrobial-resistant enterococci 
in animals and meat: a human health hazard? Foodborne Pathog Dis 7(10), 1137-46. 
Hansson, I., Engvall, E.O., Lindblad, J., Gunnarsson, A. & Vagsholm, I. (2004). Surveillance 
programme for Campylobacter species in Swedish broilers, July 2001 to June 2002. 
Vet Rec 155(7), 193-6. 
Hasman, H. & Aarestrup, F.M. (2005). Relationship between copper, glycopeptide, and 
macrolide resistance among Enterococcus faecium strains isolated from pigs in 
Denmark between 1997 and 2003. Antimicrob Agents Chemother 49(1), 454-6. 
Hegstad, K., Mikalsen, T., Coque, T.M., Werner, G. & Sundsfjord, A. (2010). Mobile 
genetic elements and their contribution to the emergence of antimicrobial resistant 
Enterococcus faecalis and Enterococcus faecium. Clin Microbiol Infect 16(6), 541-
554.   51 
Heuer, O.E., Pedersen, K., Andersen, J.S. & Madsen, M. (2002a). Vancomycin-resistant 
enterococci (VRE) in broiler flocks 5 years after the avoparcin ban. Microb Drug 
Resist 8(2), 133-8. 
Heuer, O.E., Pedersen, K., Jensen, L.B., Madsen, M. & Olsen, J.E. (2002b). Persistence of 
vancomycin-resistant enterococci (VRE) in broiler houses after the avoparcin ban. 
Microb Drug Resist 8(4), 355-61. 
Homan, W.L., Tribe, D., Poznanski, S., Li, M., Hogg, G., Spalburg, E., Van Embden, J.D. 
& Willems, R.J. (2002). Multilocus sequence typing scheme for Enterococcus 
faecium. J Clin Microbiol 40(6), 1963-71. 
Hummel, R., Tschape, H. & Witte, W. (1986). Spread of plasmid-mediated nourseothricin 
resistance due to antibiotic use in animal husbandry. J Basic Microbiol 26(8), 461-6. 
Idris, U., Lu, J., Maier, M., Sanchez, S., Hofacre, C.L., Harmon, B.G., Maurer, J.J. & Lee, 
M.D. (2006). Dissemination of fluoroquinolone-resistant Campylobacter spp. 
within an integrated commercial poultry production system. Appl Environ Microbiol 
72(5), 3441-7. 
Iversen, A., Kuhn, I., Franklin, A. & Mollby, R. (2002). High prevalence of vancomycin-
resistant enterococci in Swedish sewage. Appl Environ Microbiol 68(6), 2838-42. 
Jansson, D., Greko, C. & Bengtsson, B. Preliminary study of the effect of probiotics on 
colonization by vancomycin-resistant Enterococcus faecium in a chicken experimental 
model. In: Proceedings of XVI Congress of the World Veterinary Poultry Association, 
Marrakesh, Morocco 2009a. 
Jansson, D., Nilsson, O., Greko, C., Lindblad, J. & Bengtsson, B. Inter-batch contamination 
of broiler farms and equipment by a vancomycin-resistant clone of Enterococcus 
faecium. In: Proceedings of XVI Congress of the World Veterinary Poultry Association, 
Marrakesh, Morocco 2009b. 
Jensen, L.B., Garcia-Migura, L., Valenzuela, A.J., Lohr, M., Hasman, H. & Aarestrup, F.M. 
(2010). A classification system for plasmids from enterococci and other Gram-
positive bacteria. J Microbiol Methods 80(1), 25-43. 
Johnsen, P.J., Osterhus, J.I., Sletvold, H., Sorum, M., Kruse, H., Nielsen, K., Simonsen, 
G.S. & Sundsfjord, A. (2005). Persistence of animal and human glycopeptide-
resistant enterococci on two Norwegian poultry farms formerly exposed to 
avoparcin is associated with a widespread plasmid-mediated vanA element within a 
polyclonal Enterococcus faecium population. Appl Environ Microbiol 71(1), 159-68. 
Johnsen, P.J., Townsend, J.P., Bohn, T., Simonsen, G.S., Sundsfjord, A. & Nielsen, K.M. 
(2011). Retrospective evidence for a biological cost of vancomycin resistance 
determinants in the absence of glycopeptide selective pressures. J Antimicrob 
Chemother. 66(3): 608-610. 
Johnson, P.D., Ballard, S.A., Grabsch, E.A., Stinear, T.P., Seemann, T., Young, H.L., 
Grayson, M.L. & Howden, B.P. (2010). A sustained hospital outbreak of 
vancomycin-resistant Enterococcus faecium bacteremia due to emergence of vanB 
E. faecium sequence type 203. J Infect Dis 202(8), 1278-86. 
Kirst, H.A., Thompson, D.G. & Nicas, T.I. (1998). Historical yearly usage of vancomycin. 
Antimicrob Agents Chemother 42(5), 1303-4. 
Klare, I., Badstubner, D., Konstabel, C., Bohme, G., Claus, H. & Witte, W. (1999). 
Decreased incidence of VanA-type vancomycin-resistant enterococci isolated from   52
poultry meat and from fecal samples of humans in the community after 
discontinuation of avoparcin usage in animal husbandry. Microb Drug Resist 5(1), 
45-52. 
Klare, I., Heier, H., Claus, H., Bohme, G., Marin, S., Seltmann, G., Hakenbeck, R., 
Antanassova, V. & Witte, W. (1995a). Enterococcus faecium strains with vanA-
mediated high-level glycopeptide resistance isolated from animal foodstuffs and 
fecal samples of humans in the community. Microb Drug Resist 1(3), 265-72. 
Klare, I., Heier, H., Claus, H., Reissbrodt, R. & Witte, W. (1995b). vanA-mediated high-
level glycopeptide resistance in Enterococcus faecium from animal husbandry. 
FEMS Microbiol Lett 125(2-3), 165-71. 
Klein, G. (2003). Taxonomy, ecology and antibiotic resistance of enterococci from food and 
the gastro-intestinal tract. Int J Food Microbiol 88(2-3), 123-31. 
Kramer, A., Schwebke, I. & Kampf, G. (2006). How long do nosocomial pathogens persist 
on inanimate surfaces? A systematic review. BMC Infect Dis 6, 130. 
Kuhn, I., Iversen, A., Finn, M., Greko, C., Burman, L.G., Blanch, A.R., Vilanova, X., 
Manero, A., Taylor, H., Caplin, J., Dominguez, L., Herrero, I.A., Moreno, M.A. 
& Mollby, R. (2005). Occurrence and relatedness of vancomycin-resistant 
enterococci in animals, humans, and the environment in different European 
regions. Appl Environ Microbiol 71(9), 5383-90. 
Lauderdale, T.L., Shiau, Y.R., Wang, H.Y., Lai, J.F., Huang, I.W., Chen, P.C., Chen, 
H.Y., Lai, S.S., Liu, Y.F. & Ho, M. (2007). Effect of banning vancomycin 
analogue avoparcin on vancomycin-resistant enterococci in chicken farms in 
Taiwan. Environ Microbiol 9(3), 819-23. 
Lebreton, F., Leclercq, R., Courvalin, P. & al., e. (2010). VanN, a D-Ala-D-Ser type of 
transferable vancomycin resistance in E. faecium 08-174. Poster 41A: 3rd ASM on 
Enterococci. 
Leclercq, R., Derlot, E., Duval, J. & Courvalin, P. (1988). Plasmid-mediated resistance to 
vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 319(3), 157-
61. 
Lester, C.H., Frimodt-Moller, N., Sorensen, T.L., Monnet, D.L. & Hammerum, A.M. 
(2006). In vivo transfer of the vanA resistance gene from an Enterococcus faecium 
isolate of animal origin to an E. faecium isolate of human origin in the intestines of 
human volunteers. Antimicrob Agents Chemother 50(2), 596-9. 
Lester, C.H. & Hammerum, A.M. (2010). Transfer of vanA from an Enterococcus faecium 
isolate of chicken origin to a CC17 E. faecium isolate in the intestine of 
cephalosporin-treated mice. J Antimicrob Chemother 65(7), 1534-6. 
Lim, S.K., Kim, T.S., Lee, H.S., Nam, H.M., Joo, Y.S. & Koh, H.B. (2006). Persistence of 
vanA-type Enterococcus faecium in Korean livestock after ban on avoparcin. 
Microb Drug Resist 12(2), 136-9. 
Läkemedelsverket www.mpa.se. [online] Available from: www.mpa.se. [Accessed 2011-03-
16]. 
Martin, J.D. & Mundt, J.O. (1972). Enterococci in insects. Appl Microbiol 24(4), 575-80. 
Martins da Costa, P., Oliveira, M., Bica, A., Vaz-Pires, P. & Bernardo, F. (2007). 
Antimicrobial resistance in Enterococcus spp. and Escherichia coli isolated from 
poultry feed and feed ingredients. Vet Microbiol 120(1-2), 122-31.   53 
McCormick, M.H., McGuire, J.M., Pittenger, G.E., Pittenger, R.C. & Stark, W.M. (1955). 
Vancomycin, a new antibiotic. I. Chemical and biologic properties. Antibiotics 
annual 3, 606-11. 
McDonald, L.C., Kuehnert, M.J., Tenover, F.C. & Jarvis, W.R. (1997). Vancomycin-
resistant enterococci outside the health-care setting: prevalence, sources, and public 
health implications. Emerg Infect Dis 3(3), 311-7. 
Mead, G.C., Hudson, W.R. & Hinton, M.H. (1994). Use of a marker organism in poultry 
processing to identify sites of cross-contamination and evaluate possible control 
measures. Br Poult Sci 35(3), 345-54. 
Morrison, D., Woodford, N., Barrett, S.P., Sisson, P. & Cookson, B.D. (1999). DNA 
banding pattern polymorphism in vancomycin-resistant Enterococcus faecium and 
criteria for defining strains. J Clin Microbiol 37(4), 1084-91. 
Mundt, J.O. (1963). Occurrence of enterococci in animals in a wild environment. Appl 
Microbiol 11, 136-40. 
Nilsson, O., Greko, C., Franklin, A. & Bengtsson, B. Investigating potential sources of 
vancomycin resistant enterococci (VRE) for broilers in Sweden. In: Proceedings of 
4th Med-Vet-Net Annual Scientific Meeting, St. Malo, France, 11-14 June 2008. 
Novais, C., Coque, T.M., Costa, M.J., Sousa, J.C., Baquero, F. & Peixe, L.V. (2005). High 
occurrence and persistence of antibiotic-resistant enterococci in poultry food 
samples in Portugal. J Antimicrob Chemother 56(6), 1139-43. 
Pantosti, A., Del Grosso, M., Tagliabue, S., Macri, A. & Caprioli, A. (1999). Decrease of 
vancomycin-resistant enterococci in poultry meat after avoparcin ban. Lancet 
354(9180), 741-2. 
Patel, R. (2003). Clinical impact of vancomycin-resistant enterococci. J Antimicrob Chemother 
51 Suppl 3, iii13-21. 
Patel, R., Piper, K., Cockerill, F.R., 3rd, Steckelberg, J.M. & Yousten, A.A. (2000). The 
biopesticide Paenibacillus popilliae has a vancomycin resistance gene cluster 
homologous to the enterococcal VanA vancomycin resistance gene cluster. 
Antimicrob Agents Chemother 44(3), 705-9. 
Quednau, M., Ahrne, S., Petersson, A.C. & Molin, G. (1998). Antibiotic-resistant strains of 
Enterococcus isolated from Swedish and Danish retailed chicken and pork. J Appl 
Microbiol 84(6), 1163-70. 
Reybrouck, G. (2004). Antifungal activity of disinfectants. In: Fraise, A.P., et al. (Eds.) 
Principles and Practice of Disinfection, Preservation & Sterilization. 4th. ed. Oxford: 
Blackwell Publishing Ltd. ISBN 1-4051-0199-7. 
Reynolds, P.E. (1989). Structure, biochemistry and mechanism of action of glycopeptide 
antibiotics. Eur J Clin Microbiol Infect Dis 8(11), 943-50. 
Rosvoll, T.C., Pedersen, T., Sletvold, H., Johnsen, P.J., Sollid, J.E., Simonsen, G.S., Jensen, 
L.B., Nielsen, K.M. & Sundsfjord, A. (2010). PCR-based plasmid typing in 
Enterococcus faecium strains reveals widely distributed pRE25-, pRUM-, pIP501- 
and pHTbeta-related replicons associated with glycopeptide resistance and 
stabilizing toxin-antitoxin systems. FEMS Immunol Med Microbiol 58(2), 254-68. 
Sahlstrom, L., Rehbinder, V., Albihn, A., Aspan, A. & Bengtsson, B. (2009). Vancomycin 
resistant enterococci (VRE) in Swedish sewage sludge. Acta Vet Scand 51, 24.   54
Sakai, Y., Tsukahara, T., Bukawa, W., Matsubara, N. & Ushida, K. (2006). Cell preparation 
of Enterococcus faecalis strain EC-12 prevents vancomycin-resistant enterococci 
colonization in the cecum of newly hatched chicks. Poult Sci 85(2), 273-7. 
Sambrook, J. & Russell, D.W. (Eds.) (2001). Molecular cloning: a laboratory manual. Cold 
Spring Harbor, New York: Cold Spring Harbor Laboratory Press. 
SCENHIR (2009) Assessment of the Antibiotic Resistance Effects of Biocides. [online] Available 
from: http://ec.europa.eu/health/ph_risk/committees/04_scenihr/ 
docs/scenihr_o_021.pdf. [Accessed 2011-04-26]. 
Schjorring, S. & Krogfelt, K.A. (2011). Assessment of bacterial antibiotic resistance transfer in 
the gut. Int J Microbiol. 2011, 312956. 
Schleifer, K.H. & Kilpper-Bälz, R. (1984). Transfer of Streptococcus faecalis and Streptococcus 
faecium to the genus Enterococcus nom.rev. as Enterococcus faecalis comb. nov. and 
Enterococcus faecium comb. nov. Int J Syst Bacteriol 34(1), 31-34. 
Sherman, J.M. (1937). The Streptococci. Bacteriol Rev 1(1), 3-97. 
Slader, J., Domingue, G., Jorgensen, F., McAlpine, K., Owen, R.J., Bolton, F.J. & 
Humphrey, T.J. (2002). Impact of transport crate reuse and of catching and 
processing on Campylobacter and Salmonella contamination of broiler chickens. 
Appl Environ Microbiol 68(2), 713-9. 
Slanetz, L.W. & Bartley, C.H. (1957). Numbers of enterococci in water, sewage, and feces 
determined by the membrane filter technique with an improved medium. J 
Bacteriol 74(5), 591-5. 
Sletvold, H., Johnsen, P.J., Hamre, I., Simonsen, G.S., Sundsfjord, A. & Nielsen, K.M. 
(2008). Complete sequence of Enterococcus faecium pVEF3 and the detection of 
an omega-epsilon-zeta toxin-antitoxin module and an ABC transporter. Plasmid 
60(1), 75-85. 
Smittskyddsinstitutet Vancomycin-resistant Enterococc infection (VRE). [online] Available from: 
http://www.smittskyddsinstitutet.se/in-english/statistics/vancomycin-resistant-
enterococc-infection-vre/. [Accessed 2011-03-17]. 
Soderblom, T., Aspevall, O., Erntell, M., Hedin, G., Heimer, D., Hokeberg, I., Kidd-
Ljunggren, K., Melhus, A., Olsson-Liljequist, B., Sjogren, I., Smedjegard, J., 
Struwe, J., Sylvan, S., Tegmark-Wisell, K. & Thore, M. (2010). Alarming spread 
of vancomycin resistant enterococci in Sweden since 2007. Euro Surveill 15(29). 
Sorensen, T.L., Blom, M., Monnet, D.L., Frimodt-Moller, N., Poulsen, R.L. & Espersen, F. 
(2001). Transient intestinal carriage after ingestion of antibiotic-resistant 
Enterococcus faecium from chicken and pork. N Engl J Med 345(16), 1161-6. 
Sorum, M., Johnsen, P.J., Aasnes, B., Rosvoll, T., Kruse, H., Sundsfjord, A. & Simonsen, 
G.S. (2006). Prevalence, persistence, and molecular characterization of 
glycopeptide-resistant enterococci in Norwegian poultry and poultry farmers 3 to 8 
years after the ban on avoparcin. Appl Environ Microbiol 72(1), 516-21. 
Stokstad, E.L. & Jukes, T.H. (1950). Further observations on the " animal protein factor ". 
Proc Soc Exp Biol Med 78, 523-528. 
Stokstad, E.L., Jukes, T.H., Pierce, J., Page, A.C. & Franklin, A.L. (1949). The multiple 
nature of the animal protein factor. J Biol Chem 180(2), 647-54.   55 
SVARM (2011). Swedish Veterinary Antimicrobial Resistance Monitoring (SVARM) 2010. 
Uppsala, Sweden: The National Veterinary Institute (SVA). ISSN 1650-6332. To 
be released 9th June 2011. 
SWEDRES (2010). SWEDRES 2009. Solna, Sweden: Swedish Strategic Programme for the 
Rational Use of Antimicrobial Agents & Swedish Institute for Infectious Disease 
Control. ISSN 1400-3473. 
SWEDRES (2011). SWEDRES 2010. Solna, Sweden: Swedish Institute for Infectious 
Disease Control. ISSN 1400-3473. To be released 9th June 2011. 
Tamarin, R.H. (2004). Principles of Genetics. 7th. ed. Singapore: McGraw-Hill Education. 
Thiercelin, M. (1899). Sur un diplocoque saprophyte de l'intestin susceptible de devenir 
pathogene. C R Seances Soc Biol Fil 51, 269-271. 
Toomey, N., Monaghan, A., Fanning, S. & Bolton, D.J. (2009). Assessment of horizontal 
gene transfer in Lactic acid bacteria--a comparison of mating techniques with a 
view to optimising conjugation conditions. J Microbiol Methods 77(1), 23-8. 
Torell, E., Fredlund, H., Tornquist, E., Myhre, E.B., Sjoberg, L. & Sundsfjord, A. (1997). 
Intrahospital spread of vancomycin-resistant Enterococcus faecium in Sweden. 
Scand J Infect Dis 29(3), 259-63. 
Trobos, M., Lester, C.H., Olsen, J.E., Frimodt-Moller, N. & Hammerum, A.M. (2009). 
Natural transfer of sulphonamide and ampicillin resistance between Escherichia coli 
residing in the human intestine. J Antimicrob Chemother 63(1), 80-6. 
Tschape, H. (1994). The spread of plasmids as a function of bacterial adaptability. FEMS 
Microbiology Ecology 15, 23-32. 
Uttley, A.H., Collins, C.H., Naidoo, J. & George, R.C. (1988). Vancomycin-resistant 
enterococci. Lancet 1(8575-6), 57-8. 
Walsh, C. (2003). Antibiotics: actions, origins, resistance. Washington, DC: ASM Press. 
van Belkum, A., Tassios, P.T., Dijkshoorn, L., Haeggman, S., Cookson, B., Fry, N.K., 
Fussing, V., Green, J., Feil, E., Gerner-Smidt, P., Brisse, S. & Struelens, M. (2007). 
Guidelines for the validation and application of typing methods for use in bacterial 
epidemiology. Clin Microbiol Infec 13 Suppl 3, 1-46. 
van den Bogaard, A.E., Bruinsma, N. & Stobberingh, E.E. (2000). The effect of banning 
avoparcin on VRE carriage in The Netherlands. J Antimicrob Chemother 46(1), 146-
8. 
van den Braak, N., van Belkum, A., van Keulen, M., Vliegenthart, J., Verbrugh, H.A. & 
Endtz, H.P. (1998). Molecular characterization of vancomycin-resistant 
enterococci from hospitalized patients and poultry products in The Netherlands. J 
Clin Microbiol 36(7), 1927-32. 
Wegener, H.C. (1998). Historical yearly usage of glycopeptides for animals and humans: the 
American-European paradox revisited. Antimicrob Agents Chemother 42(11), 3049. 
Werner, G., Coque, T.M., Hammerum, A.M., Hope, R., Hryniewicz, W., Johnson, A., 
Klare, I., Kristinsson, K.G., Leclercq, R., Lester, C.H., Lillie, M., Novais, C., 
Olsson-Liljequist, B., Peixe, L.V., Sadowy, E., Simonsen, G.S., Top, J., Vuopio-
Varkila, J., Willems, R.J., Witte, W. & Woodford, N. (2008). Emergence and 
spread of vancomycin resistance among enterococci in Europe. Euro Surveill 13(47). 
WHO (2009). WHO list of critically important antimicrobials for human medicine. Geneva: WHO.   56
WHO WHO, Programmes and projects, Zoonoses and veterinary public health. [online] [Accessed 
2011-03-16]. 
Vidal, M., Forestier, C., Charbonnel, N., Henard, S., Rabaud, C. & Lesens, O. (2010). 
Probiotics and intestinal colonization by vancomycin-resistant enterococci in mice 
and humans. J Clin Microbiol 48(7), 2595-8. 
Wierup, M., Lowenhielm, C., Wold-Troell, M. & Agenas, I. (1987). Animal consumption 
of antibiotics and chemotherapeutic drugs in Sweden during 1980, 1982 and 1984. 
Vet Res Commun 11(5), 397-405. 
Willems, R.J., Top, J., van Den Braak, N., van Belkum, A., Endtz, H., Mevius, D., 
Stobberingh, E., van Den Bogaard, A. & van Embden, J.D. (2000). Host specificity 
of vancomycin-resistant Enterococcus faecium. J Infect Dis 182(3), 816-23. 
Witte, W. (1998). Medical consequences of antibiotic use in agriculture. Science 279(5353), 
996-7. 
Witte, W. (2000). Selective pressure by antibiotic use in livestock. Int J Antimicrob Agents 16 
Suppl 1, S19-24. 
Woodford, N., Adebiyi, A.M., Palepou, M.F. & Cookson, B.D. (1998). Diversity of VanA 
glycopeptide resistance elements in enterococci from humans and nonhuman 
sources. Antimicrob Agents Chemother 42(3), 502-8. 
Xu, X., Lin, D., Yan, G., Ye, X., Wu, S., Guo, Y., Zhu, D., Hu, F., Zhang, Y., Wang, F., 
Jacoby, G.A. & Wang, M. (2010). vanM, a new glycopeptide resistance gene 
cluster found in Enterococcus faecium. Antimicrob Agents Chemother 54(11), 4643-7. 
Yoshimura, H., Ishimaru, M., Endoh, Y.S., Suginaka, M. & Yamatani, S. (1998). Isolation of 
glycopeptide-resistant enterococci from chicken in Japan. Antimicrob Agents 
Chemother 42(12), 3333. 
 
 
     57 
Acknowledgements 
The studies were carried out at the Department of Animal Health and 
Antimicrobial Strategies at the National Veterinary Institute (SVA) in 
association with the division of Ruminant Medicine and Veterinary 
Epidemiology, Department of Clinical Sciences, Swedish University of 
Agricultural Sciences (SLU), Uppsala, Sweden. 
The main financial support was kindly provided by the Swedish Farmers’ 
Foundation for Agricultural Research and SVARMpat. Other sources of 
financial support were Med-Vet-Net, the Royal Swedish Academy of 
Agriculture and Forestry (KSLA), SVA vaccine fund, Albert Hjärre fund, 
Ivar and Elsa Sandbergs fund and SLU fund for internationalisation of 
postgraduate studies (FUR). 
Apart from the above mentioned organisations I would like to express my
 sincere gratitude to anyone who feels that he or she has contributed to this  
thesis. If you feel so, it is probably true even if I have forgotten to 
specifically mention you in the following list. 
My supervisors: 
Ivar Vågsholm for always being there as my main supervisor, no matter 
where in the academic or the real world you have been. 
Björn Bengtsson for being my closest supervisor and the one most 
involved in my project – I hope you understand how grateful I am for all 
the work you have done and for all your support. I also appreciate your 
calm analysis, your positivity and that you have always supported taking 
time off from work to go hunting.   58
Stina Englund for sticking in until the end when I finally started doing 
something that you liked and could relate to. 
Claes Fellström for filling the missing part of my supervisor group and for 
telling me about the wonders of SLU. 
Anders Franklin for teaching me how to handle the bureaucracy of SVA 
and for the discussions during the coffee breaks, and especially for telling me 
how life in Upplands Väsby is. 
Christina Greko f o r  t e a c h i n g  m e  t o  b e  s t r i n g e n t ,  f o r  a l w a y s  b e i n g  
enthusiastic about my plans for the future and for never saying no to a calva. 
The project advisory group, Désirée Jansson,  H-C Palmers,  Johan 
Lindblad and Pia Gustafsson, for valuable input regarding the project. 
All  farmers and others that have sent me samples during these years. 
Especially the farmers on whose farms I was allowed to perform the studies 
related to Paper III and IV. And I am truly sorry for the damaged 
equipment... 
All other persons around me: 
Anyone that has ever provided me with biscuits, cakes or candy. 
Anyone that has ever made me have a beer and a burger. 
Janetta, Rob, Helen, Willem and all the others in Utrecht for guiding 
me through the scientific world of enterococci. 
K Dahl for the nice illustrations in Figure 1 and for being a great “cousin”. 
Grant Smith for teaching me Queen’s English. 
The lab-ladies, Annica Landén,  Eva Hübbinette,  Kerstin Ekström, 
Margareta Horn af Rantzien and Maria Finn, for doing my lab-work 
when I did not have the time (or the desire) to do it myself. 
Susanna Thyselius and Stefan Börjesson for being such great office 
mates and establishing a good mix of hard work and random nonsense.   59 
Ulrika Grönlund-Andersson f o r  m a k i n g  s u r e  t h a t  m y  e n v i r o n m e n t a l  
conscience stayed alert. 
Helle Ericsson Unnerstad for not being an old discharged bacteriologist 
and for showing the wonderful gingerbread houses at work. 
Tony Österdahl for English consulting, great barbeque and insistent 
attempts to get met to start running. 
Other  people at DOA for talking to loud in the coffee room and for 
boring enhetsmöten. But also for all the good things and all the laughter. 
Everyone at the Campylobacter lab at the Department of Bacteriology for 
providing me with high quality broiler shit. 
Märit Pringle and her colleagues at Department of Biomedical Sciences 
and Veterinary Public Health, SLU, for letting me use some of their 
equipment and for always being happy and encouraging. 
Everyone attending the EpiForum for interesting discussions. 
Past and present PhD colleagues, both at SVA and SLU for giving me 
perspective on my project, for giving me ideas about alternative methods 
and for being great friends. 
Anna-Maria, Marie, Åsa and Patrik for gossiping during dog walks and 
for sometimes helping me with Fanny. 
Jonas Malmsten for always being my friend, helping me out and 
understanding my dialect. 
My parents, my brother and sister and their families for being you. 
My beloved Malin for everything. ΙSpread without known selective pressure of a vancomycin-resistant
clone of Enterococcus faecium among broilers
O. Nilsson1*, C. Greko1,J .T o p 2, A. Franklin1 and B. Bengtsson1
1National Veterinary Institute, Uppsala, Sweden;
2University Medical Center, Utrecht, The Netherlands
Received 14 November 2008; returned 12 December 2008; revised 29 January 2009; accepted 30 January 2009
Objectives: The aim of this paper was to describe an increased occurrence of vancomycin-resistant
enterococci (VRE) in Swedish broilers since 2000 and to investigate the genetic relatedness of
isolates.
Methods: Caecal content from slaughtered broilers was cultured for VRE on medium supplemented
with vancomycin (16 mg/L). Species identiﬁcation, antibiotic susceptibility determination, vancomycin
resistance genotyping, multilocus sequence typing (MLST) and characterization of Tn1546 were
performed.
Results: The proportion of VRE-positive samples increased gradually from <1% in 2000 to slightly over
40% in 2005. Between 2005 and 2006, the proportion of VRE-positive samples decreased and between
2006 and 2007, it was stable at just below 30%. All isolates tested were Enterococcus faecium and
carried the vanA gene. A majority of the isolates had similar antibiograms, the same MLST sequence
type and Tn1546 transposon.
Conclusions: The proportion of VRE-positive samples from broilers has increased since 2000, and this
is due to the spread of one major clone. Moreover, this has taken place in an environment without any
obvious selective pressure.
Keywords: epidemiology, MLST, vanA
Introduction
The glycopeptide vancomycin is an antimicrobial that, in human
medicine, is primarily used to treat infections with Gram-
positive bacteria resistant to other antimicrobials. Enterococci
are ubiquitous microorganisms and are a part of the normal
intestinal ﬂora of man and many other animals. Traditionally,
enterococci were considered to be low-grade pathogens with
little clinical relevance. During the last two decades, this has
changed and they are now increasingly important as opportunis-
tic pathogens causing nosocomial infections in immunocompro-
mised patients.
1 An increasing proportion of these infections are
caused by vancomycin-resistant enterococci (VRE) ﬁrst isolated
in 1986.
1,2
In the 1990s, Enterococcus faecium carrying the vanA gene,
i.e. VRE, were common in the intestinal ﬂora of farm animals in
Europe, mainly due to the extensive use of the glycopeptide
growth promoter avoparcin.
3 When the association between avo-
parcin and VRE was conﬁrmed, its use was discontinued, ﬁrst in
Denmark, Finland and Norway and eventually, in 1997, in the
whole of the European Union (Commission Directive 97/6 EC).
The main reason for this was to evade a pool of VRE that could
potentially spread into the community and further into hospital
settings.
1 After the withdrawal of avoparcin, the prevalence of
VRE in farm animals in Europe rapidly declined.
4
In Sweden, no growth promoters have been used since 1986,
and the use of avoparcin was discontinued even before that.
Avoparcin was only used for some years in the late 1970s and
early 1980s at quantities of about eight tons per year.
5
Consequently, the situation in Sweden differed from that in
other European countries, and VRE were not isolated in samples
from Swedish broilers in the middle of the 1990s.
6 Using
medium supplemented with vancomycin, VRE were isolated
from the intestinal contents from 4 of 150 broilers and 1 of 306
pigs in a survey conducted from 1998 to 2000.
7
Since 2000, the presence of VRE in the intestinal contents
from broilers and other farm animals has been regularly
monitored as part of the Swedish Veterinary Antimicrobial
Resistance Monitoring (SVARM) programme.
8 In this pro-
gramme, VRE have not been isolated from pigs or cattle and
only rarely in samples from broilers when medium without
vancomycin was used for bacteriological culture. However,
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proportion of samples from broilers when medium supplemented
with vancomycin was used. The aim of this paper was to
describe this increase and to investigate the genetic relatedness
of isolates.
Materials and methods
Sampling
From 2000 to 2002 and from 2004 to 2007, caeca from healthy
broilers were collected at slaughterhouses. Samples were collected
throughout the year except for 2005 and 2006, when samples
were only collected during one spring and one autumn month. All
samples were from unique broiler ﬂocks, but not from unique pro-
duction sites. In 2000 and 2001, samples were collected at four
slaughterhouses representing 40% of the total annual slaughter of
broilers in Sweden. Additional slaughterhouses were included so
that in 2002  70% and from 2004 onwards over 90%, of the
total annual slaughter was covered. Initially, mainly ﬂocks from
the southwest and southeast of Sweden were sampled. As
additional slaughterhouses were included, the remaining parts of
the country where broiler chickens are produced were also
covered.
Bacterial isolation and identiﬁcation
Caecal content (0.5 g) was suspended in 4.5 mL of saline from
which 0.1 mL was streaked on Slanetz–Bartley agar (Oxoid,
Basingstoke, UK) supplemented with vancomycin (Sigma-Aldrich,
Steinheim, Germany) and incubated at 378C for 48 h. The vancomy-
cin concentration in the Slanetz–Bartley agar was 8 mg/L during
2000–02. From 2004 onwards, the concentration was 16 mg/L.
Moreover, between 2000 and 2002, an enrichment step, i.e. incu-
bation in Enterococcosel (Merck, Darmstadt, Germany) sup-
plemented with vancomycin (ﬁnal concentration of 8 mg/L) at 378C
for 24 h, was included before culture on solid medium.
From plates with growth of colonies typical for enterococci, at
least one colony was subcultured on blood agar (Oxoid) and
Bile-Esculine agar (Oxoid) and incubated at 378C for 24 h.
Presumptive enterococci were identiﬁed to species level according
to Devriese et al.
9 Isolates were stored at 2708C for further
investigations.
Susceptibility testing
Susceptibility against a panel of antimicrobials (Table 2) was tested
by the determination of MIC using microdilution methods according
to the standards of the CLSI.
10 The Enterococcus faecalis reference
strains ATCC 29212 and ATCC 33186 were used for quality
control. The tests were performed using cation-adjusted Mueller–
Hinton broth (Difco, Sparks, USA) using VetMICTM E-cocci panels
(SVA, Uppsala, Sweden). Susceptibility data were interpreted
according to epidemiological cut-off values suggested by EUCAST
(http://www.eucast.org), except for narasin where a cut-off of
.2 mg/L was used instead of the recommended value of .4 mg/L.
Isolates with MICs above the wild-type cut-off value were
considered resistant.
Investigation of resistance genotype
In a subset of isolates, the gene encoding vancomycin resistance
was determined using PCR for the vanA gene.
11 During 2000 and
2001, all VRE isolates obtained were investigated and from 2002
through 2005 every fourth, in 2006 every third and in 2007 every
ﬁfth consecutive isolate was investigated. In total, 117 out of 384
isolates obtained were investigated.
Multilocus sequence typing (MLST)
To determine the genetic relatedness of VRE isolates, MLST was
performed as described previously by Homan et al.,
12 with modiﬁ-
cations as described on the MLST web site (http://www.mlst.net). In
total, 48 VRE isolates from Swedish broilers were analysed, includ-
ing the ﬁrst 2 isolates from 2000 and 46 isolates selected at random
from the total of 338 isolates obtained from January 2001 until
June 2007.
Tn1546 transposon typing
For the 48 VRE isolates typed by MLST, the vanA-containing
Tn1546 transposon was typed using an overlapping PCR method
modiﬁed from Woodford et al.
13 Brieﬂy, the primers were adjusted
(Table 1), and a touchdown PCR strategy was employed using
HotStarTaq master mix (Qiagen GmbH, Germany). The initial dena-
turation step of 15 min at 958C was followed by 10 cycles consisting
of 30 s at 948C, 30 s at 618Cd o w nt o5 1 8C and 1 min at 728C, fol-
lowed by 30 cycles of 30 s at 948C, 30 s at 518C and 1 min at 728C,
Table 1. The 10 primer pairs used for Tn1546 transposon typing
Sequences (50 !30)
forward primer reverse primer
Primer pair 1 GGA TTT ACA ACG CTA AGC C GCC TTT ATC AGA TGC TAC C
Primer pair 2 GGT TTT CGA TTA TTG GAA G TAA AAA TAA TAG AAC GCA TCG AAT AC
Primer pair 3 CTT GAA AGT CAC GGA ATG GGT TAA CAC CAG CCA TTA C
Primer pair 4 GGA TGG ACT AAC ACC AAT C GTA TAA TTC AAC CAA ATC GG
Primer pair 5 GTG AAG GGA TTG AAT TGG CCA ATC CCC AAG TTT CC
Primer pair 6 CGA CTA TTC CAA ACT AGA ACG A CAT AGT ATA ATC GGC AAC GC
Primer pair 7 CTT CTT GCG CTG AAG AG CTA TTT CCA TGC TTA TCA CC
Primer pair 8 CAG GAG CAT GAA TAG AAT AAA AG GGA TTT ACT ATT ATC ACC AAT GTA G
Primer pair 9 CAC TTA TGA AAA TTC ATC TAC ATT G CCA AGA AAG CCT CCA ACA
Primer pair 10 GCT ATT GGA GCG ACA GAC A GCG GAT TTA CAA CGT TAA G
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869with a ﬁnal extension step of 7 min at 728C. BM4147 was included
as a positive control. The result was visualized by running the PCR
products on a 1% agarose gel with 0.01% ethidium bromide.
Statistical analysis
Differences in the proportion of VRE-positive samples between
years were tested with Pearson’s x
2 test using Stata software
(release 10, Stata, College Station, TX, USA).
Results
VRE isolation and identiﬁcation
VRE were isolated from 384 of the 1853 samples cultured
between 2000 and 2007 (Figure 1). All VRE were E. faecium
with MICs of vancomycin of .64 mg/L. The proportion of
VRE-positive samples increased gradually from ,1% in 2000 to
slightly over 40% in 2005. Between 2005 and 2006, the pro-
portion of VRE-positive samples decreased and from 2006 to
2007, it was stable at just below 30%. The difference in the pro-
portion of VRE-positive samples between years was statistically
signiﬁcant (x
2 test, P 0.001).
Resistance phenotype and genotype
All VRE were high-level vancomycin-resistant (MIC.64 mg/L),
and all isolates investigated by PCR (n¼117) carried the vanA
gene. In addition, the majority of isolates (89.6%) had a pheno-
type also including resistance to narasin (MIC 4–16 mg/L) and
erythromycin (MIC 8–16 mg/L) (Table 2). A minority of
isolates had other resistance phenotypes (Table 2), including two
isolates with MICs of ampicillin of 8 mg/L, i.e. just above the
cut-off value.
MLST
MLST analysis of 48 VRE isolates revealed three different
sequence types (STs). The 46 randomly selected isolates from
2001 to 2007 appeared to have ST310, whereas the two isolates
from 2000 had ST13 and ST370.
Tn1546 transposon typing
All investigated isolates rendered PCR products for all 10 primer
pairs, and the products for each primer pair were of the same
size for all the isolates. The proﬁle of the investigated strains
was the same as that of BM4147, indicating identical Tn1546
transposons (Figure 2).
Discussion
Since 2000, the proportion of VRE-positive samples from
Swedish broilers has increased considerably. MLST analysis
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Figure 1. Proportion of VRE-positive samples from broilers from 2000 to
2007; 95% conﬁdence intervals are indicated. The numbers of positive and
cultured samples are given in brackets. No samples were analysed in 2003.
Table 2. Antibiograms of VRE from Swedish broilers (n¼384) from 2000 until 2007
No. of isolates (%)
Resistance pattern
VAN NAR ERY BAC TET AMP VIR STR GEN
344 (89.6) R R R S S S S S S
14 (3.6) R R S S S S S S S
11 (2.8) R R S R S S S S S
9 (2.3) R R R S S S R S S
2 (0.5) R R S S R S S S S
1 (0.3) R R S S S R S S S
1 (0.3) R R S S S S R S S
1 (0.3) R R R S R S S S S
1 (0.3) R R R R S R S S S
R, resistant; S, susceptible.
Resistance corresponds to MICs above the epidemiological cut-off values suggested by EUCAST (http://www.eucast.org). However, for narasin, a cut-off of
.2 mg/L was used instead of the recommended value of .4 mg/L, and for streptomycin and gentamicin, only high-level resistance (MIC.256 mg/L) was
evaluated.
Antimicrobials included and cut-off values (mg/L) used are vancomycin (VAN, .4), narasin (NAR, .2), erythromycin (ERY, .4), bacitracin (BAC, .32),
tetracycline (TET, .2), ampicillin (AMP, .4), virginamycin (VIR, .4), streptomycin (STR, .256) and gentamicin (GEN, .256).
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870revealed that this is due to the spread of one major clone of
E. faecium carrying the same Tn1546 type. The increase is
evident when vancomycin-supplemented medium is used, but
there is no apparent change in the prevalence of vancomycin
resistance among randomly selected E. faecium.
8 This indicates
that only a small proportion of enterococci in the intestinal ﬂora
of broilers are VRE. This is in contrast to the course of events in
other parts of Europe. When avoparcin was still in use during
the 1990s, up to 80% of randomly selected E. faecium from
broilers were vancomycin-resistant.
14 After the withdrawal of
avoparcin in Europe, there was a sharp reduction in the pro-
portion of VRE among randomly selected E. faecium from intes-
tinal contents.
15 This indicates a decline in actual numbers.
However, a high prevalence of VRE is still found in broilers
when medium supplemented with vancomycin is used.
16 In
Sweden, avoparcin has not been used since the early 1980s, and
the prevalence of VRE among Swedish broilers and their poss-
ible clonality at that time are not known in detail. In studies
from the late 1990s, only occasional isolates of VRE were
found.
6,7 Also the diversity of the VRE population among broi-
lers is different between Sweden and the rest of Europe. In
Europe, several different strains of VRE have been isolated,
even on the same farm and sampling occasion.
17 This is in con-
trast to the apparent clonality of isolates from Swedish broilers
shown by MLST in this study.
In Sweden, there is currently no obvious selection pressure
for VRE in broiler production. Avoparcin has, as previously
mentioned, not been used since the early 1980s, indicating that
vancomycin resistance per se is not the selective advantage of
the clone. Ionophores are commonly used for prophylaxis
against coccidiosis, but selection for VRE by this use is unlikely
since ionophore resistance is widespread also among vancomycin-
susceptible enterococci from Swedish broilers.
8 Moreover,
therapeutic use of antimicrobials is rare in Swedish broiler pro-
duction. Instead, the emphasis is on disease control by bio-
security, including hygiene barriers and a strict all-in all-out
procedure.
The increase in the proportion of VRE-positive samples since
2000 could be explained by the introduction of VRE or the
emergence of a very competitive strain, in the late 1990s.
Alternatively, there could have been changes in management at
that time favouring persistence and transmission of VRE. Yet
another scenario is that the explanation lies in a combination of
these factors. The fact that only three different MLST STs have
been documented indicates that VRE in Swedish broilers did not
emerge due to selective pressure by avoparcin, i.e. there has
probably been an introduction at some point after the withdrawal
of avoparcin. That the two STs found in 2000 (ST13 and
ST370) were not re-isolated indicates that glycopeptide resist-
ance is not the selective advantage of the dominating clone
(ST310).
The reason for discontinuing the use of avoparcin in the EU
was to avoid a pool of resistance genes among farm animals that
could, via the food chain, inﬂuence the situation in human medi-
cine. The potential for such an inﬂuence was indirectly indicated
by the reduced prevalence of VRE in healthy humans observed
after the withdrawal of avoparcin.
15 Since only a small pro-
portion of enterococci in the intestinal ﬂora of broilers are VRE,
and since chicken meat is normally thoroughly heat-treated
before consumption, the risk of such a spillover in Sweden is
low. Infections caused by VRE are still uncommon in Sweden
and, in addition, the majority of human cases are caused by
E. faecium carrying the vanB gene.
18 Therefore, the presence of
VRE among Swedish broilers does not seem to have affected
the situation within Swedish healthcare. Nor is it clear if the
situation in the community is affected. Two separate studies on
sewage, as an indicator of community carriage, gave contradic-
tive results with 5% and 54% of VRE, respectively, being
E. faecium carrying the vanA gene.
19,20 Nevertheless, a pool of
resistance genes in production animals is unwanted. Therefore,
studies aimed at counteracting the spread and persistence of
ST310 are warranted. This includes identifying routes of spread
and possible selective pressures, as well as selective advantages
of ST310.
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Figure 2. Electrophoresis gel comparing the Tn1546 transposon patterns of
a representative strain (lanes 2, 4, 6, 8, 10, 12, 14, 16, 18 and 20) and
reference strain BM4147 (lanes 3, 5, 7, 9, 11, 13, 15, 17, 19 and 21). Lanes
1 and 22 contain 1 kb ladder (Promega, Benelux, B.V.).
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Abstract 
One clone of vancomycin resistant Enterococcus faecium with the vanA gene 
(VRE) is predominant among Swedish broilers but other clones do exist. In 
this study, the molecular diversity among the clones is investigated. The 
aims of the study were to better understand why one clone of VRE is 
predominant in Swedish broiler production and to better assess the potential 
for zoonotic gene transfer from the different clones. 
A total of 26 isolates were separated into 11 clones. Vancomycin resistance 
was transferrable from the predominant and five of the minority clones. 
Decreased susceptibility to narasin was co-transferred with the vancomycin 
resistance in four of the clones, including the predominant one. The plasmid 
addiction system axe-txe was not detected, and the ω-ε-ζ system was 
detected in one of the minority clones but it was not co-transferred with the 
vancomycin resistance. 
The results of this study do not explain why one clone is predominant 
among VRE in Swedish broiler production but the results confirm the 
potential for zoonotic spread of vancomycin resistance genes. The near 
absence of investigated plasmid addiction systems indicates that they do not 
play an important role in the epidemiology of VRE in Swedish broiler 
production. On the other hand, the coincidental finding that decreased 
susceptibility to narasin can be co-transferred with the vanA gene indicates 
that the use of narasin might play a role in the persistence of vancomycin 
resistance in enterococci in Swedish broiler production. 
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Introduction 
Vancomycin resistant enterococci (VRE) of the vanA genotype were found 
in abundance among production animals in the 1990’s due to use of the 
glycopeptide avoparcin as growth promoter (Hammerum et al., 2010). The 
common occurrence was thought to be of importance for the epidemiology 
of VRE in human healthcare through dissemination of the vanA gene to 
enterococci adapted to humans (Hammerum et al., 2010). Such transfer has 
been documented to occur in vivo (Lester et al., 2006). The perceived risk of 
a reservoir of resistance genes in production animals lead to a 
discontinuation of the use of avoparcin with a subsequent reduction in 
prevalence of VRE in food producing animals (Sundsfjord et al., 2001; 
Anonymous, 1997). 
The situation regarding VRE in Swedish broiler production differs from 
that in other parts of Europe in several ways. For example, one clone of 
vanA carrying E. faecium is predominant even if other minority clones are 
also found (Nilsson et al., 2009b). It is known that VRE persists at Swedish 
broiler farms between batches of birds but attempts to explain the 
epidemiology by differences in management routines of farms have not been 
successful (Jansson et al., 2009; Nilsson et al., 2009a). Furthermore, there is 
currently no known selective pressure favouring VRE in Swedish broiler 
production. Growth promoting antimicrobials have not been used since 
1986 and therapeutic use of antimicrobials is rare although the ionophore 
narasin is routinely used for prophylaxis of coccidiosis (SVARM, 2010). 
Persistence of VRE in Norwegian broiler production after discontinued 
avoparcin use has been attributed to linkage between the vancomycin 
resistance and the ω-ε-ζ plasmid addiction system (Johnsen et al., 2005). 
Similarly, presence of the ω-ε-ζ or other plasmid addiction systems could be 
an explanation for the persistence of vancomycin resistance in enterococci 
also in Swedish broiler production. 
Understanding the epidemiology of VRE in Swedish broiler production is 
important in order to underpin intervention strategies. Increased knowledge 
regarding the genetic diversity among VRE from Swedish broilers could 
provide pieces in the epidemiological puzzle. Traits that could be of 
importance are the presence of common genetic elements like specific 
plasmids or variants of the Tn1546 transposon. Another factor contributing 
to the situation with one predominant clone is if the vancomycin resistance 
is not transferrable. The possible transferability of the vanA gene is also one 
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factor in properly assessing the potential for zoonotic gene transfer from the 
clones of VRE in Swedish broiler production. 
The aims of this study were to explore why one clone of VRE is 
predominant in Swedish broiler production and to better assess the potential 
for zoonotic gene transfer from the clones. Therefore, clones of VRE from 
Swedish broilers were identified and molecularly characterized. 
Material and Methods 
Description of isolates 
Isolates were chosen from a collection of VRE isolated from Swedish 
broilers between 1998 and 2009 through the Swedish Veterinary 
Antimicrobial Resistance Monitoring programme (SVARM) or the 
European research programme for Agriculture and Fisheries (FAIR) (Kuhn 
et al., 2005; SVARM). From this collection, one isolate of the VRE clone 
dominating among Swedish broilers was selected. Further, isolates with 
resistance phenotypes different from the phenotype of the dominating clone 
were selected (Table 1). Three of the isolates have been previously described 
(Nilsson et al., 2009b) and the remaining 23 isolates were characterized with 
MLST (Anonymous, 2008; Homan et al., 2002). Then from the 26 isolates, 
1 isolate representing each combination of ST and resistance pattern (n=11, 
hereafter called clone representatives) was chosen at random for further 
characterization (Table 2). 
Transferability of vancomycin resistance 
The ability of the clone representatives to transfer vancomycin resistance 
was investigated by filter mating as previously described by Hammerum et 
al. (Hammerum et al., 1998). The plasmid free Enterococcus faecium 64/3 
(Werner et al., 2003) was used as recipient and E. faecium F9730129-1 as 
positive control. 
The susceptibility of the transconjugants to various antimicrobials (Table 1) 
was tested by determination of MIC using a microdilution method 
according to standards of the CLSI (2008). The E. faecalis reference strains 
ATCC 29212 was used for quality control. The tests were performed using 
cation-adjusted Mueller–Hinton broth (Difco, Sparks, USA) and VetMIC
TM 
E-cocci panels (SVA, Uppsala, Sweden). Results were interpreted according 
to epidemiological cut-off values issued by EUCAST (2011). The absence 
of the vanA gene in the recipient and the presence of vanA in clone 
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representatives and in transconjugants was confirmed by PCR (Dutka-
Malen et al., 1995). 
To confirm that isolates obtained via filter mating were true transconjugants 
their genetic relationship to the clone representatives and the recipient strain 
was investigated by pulsed-field gel electrophoresis (PFGE). Total DNA in 
agarose gel plugs were treated with SmaI (New England BioLabs, Ipswich, 
UK) before separation by PFGE using a CHEF Mapper apparatus (BioRad 
Laboratories, Richmond California, USA) with settings as previously 
described (Rosvoll et al., 2010; Sahlstrom et al., 2009). Band patterns were 
analyzed using BioNumerics 5.10 (Applied Maths, Belgium) with settings 
according to Werner et al. (2007). 
Tn1546 transposon typing 
The Tn1546 transposon in the clone representatives and the transconjugants 
was typed using an overlapping PCR as previously described (Nilsson et al., 
2009b; Woodford et al., 1998), with the modification that a standard and 
not a touchdown PCR strategy was used. 
Plasmid analyses 
The number of plasmids and their size in the clone representatives, the 
recipient strain and the transconjugants were analyzed by digestion with S1 
nuclease (Sigma-Aldrich, Stockholm, Sweden) as previously described 
(Barton et al., 1995) before separation by PFGE as described above. 
The presence of five enterococcal plasmid replicon types (pRE25, pEF418, 
pIP501, pRUM and pHTβ) and two plasmid addiction systems (axe-txe and 
ω-ε-ζ) in the clone representatives and the transconjugants were investigated 
by PCR as previously described (Jensen et al., 2010; Rosvoll et al., 2010; 
Sletvold et al., 2008). 
To study if vancomycin resistance is plasmid mediated in clone 
representatives and transconjugants, plasmid DNA was isolated with 
QIAprep (Qiagen AB, Solna, Sweden). Then, remaining chromosomal 
DNA was removed by digestion with Plasmid-Safe ATP-Dependent DNase 
(Epicentre Biotchnologies, Wisconsin, USA) according to manufacturers’ 
instructions and as previously described (Moritz & Hergenrother, 2007). 
Finally, PCR for the vanA gene was performed as for the Tn1546 
transposon typing described above. The absence of chromosomal DNA was 
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confirmed by PCR for the atpA gene as for the MLST scheme described 
above. 
Results 
Description of isolates 
The isolates belonged to eight different STs, including one previously not 
described (assigned ST587) and had six different resistance patterns (Table 
1). They separated into eleven different combinations of ST and resistance 
pattern, and from each of the combinations one clone representative (n=11) 
was further characterized (Table 2). 
Transferability of vancomycin resistance 
Six of the clone representatives transferred vancomycin resistance at 
frequencies varying from 10
-4 – 10
-8 per donor cell (mean varying from 10
-4 
– 10
-7), compared to a frequency of 10
-7 – 10
-8 for the positive control (Table 
2). 
The SmaI PFGE digestion patterns for the recipient and the transconjugants 
had more than 90% similarity but less than 65% similarity to the clone 
representatives from which vancomycin resistance was transferred. This 
confirms that the transconjugants originate from the recipient strain (Figure 
1). The overall similarity among the different clone representatives was 72%. 
The MIC of vancomycin for the transconjugants was >128 mg/L whereas 
the MIC of the recipient was ≤1 mg/L. From four of the isolates, decreased 
susceptibility to narasin was co-transferred with vancomycin resistance 
(Table 2). The MIC of narasin for these transconjugants were 2 or 4 mg/L 
compared to 4 or 8 mg/L for their respective clone representatives and 0.25 
mg/L for the recipient. Co-transfer of resistance to bacitracin, 
erythromycin, tetracycline or virginamycin was not observed. 
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Figure 1. Dendrogram and SmaI digestion patterns of the clone representatives, the recipient 
strain and the transconjugants. 
Tn1546 transposon typing 
Among the clone representatives, all but one isolate had a Tn1546 
transposon of the E. faecium BM4147 prototype variant, i.e. Type A variant 
according to the classification of Woodford et al. (Table 2) (1998). The 
remaining isolate (FAIR sb075) was of Type P according to the same 
classification. All transconjugants had the prototype variant of the Tn1546 
transposon. 
Plasmid analyses 
Using S1 nuclease and PFGE, between one and four plasmids in the range 
of 25 to 200 kilobases (kb) were seen in the clone representatives (Figure 2 
and Table 2). In the recipient no plasmid, and in each of the transconjugants 
only one plasmid was seen. For all transconjugants, the size of the plasmid 
corresponded to a plasmid in their respective clone representative. 
The plasmid replicon type pRE25 was detected among the clone 
representatives and the transconjugants but not pEF418, pIP501, pRUM or 
pHTβ (Table 2). Despite repeated attempts, none of the tested plasmid 
replicon types was detected in nine of the isolates (five clone representatives 
and four transconjugants). Of the two plasmid addiction systems, only ω-ε-ζ 
was detected and only in one of the clone representatives (Table 2). 
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Analyses with PCR on plasmid DNA were negative for the atpA gene 
confirming that any remnants of chromosomal DNA were removed by the 
DNase. Contrary, plasmid DNA from all clone representatives and 
transconjugants were positive for the vanA gene. 
Figure 2. Plasmids detected by S1 nuclease analyses in the transconjugants and their respective 
clone representatives. The scale indicates size of the plasmids in kilobases. 
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Table 1. Sequence types and resistance patterns of the included VRE. 
Resistance pattern 
Isolate MLST  Va  Na  Em Ba  Te  Ap  Vm Sm  Gm 
SVARM 2001-233¤*    310  >128 8  32  2  1  2  2  64  16 
SVARM 2005-028*    8  >128 8  4  ≤1  ≤0.5 2  2  32  8 
FAIR sb075*    9  >128 8  1  32  ≤0.5 4  1  64  8 
SVARM 2002-082    9  >128 4  1  8  ≤0.5 4  2  64  8 
SVARM 2007-293*    10  >128 4  ≤0.5 ≤1  ≤0.5 4  2  32  4 
SVARM 2002-347*    310  >128 8  4  ≤1  ≤0.5 2  4  32  8 
SVARM 2005-043    310  >128 8  4  ≤1  ≤0.5 2  2  64  8 
SVARM 2006-054    310  >128 8  4  ≤1  1  2  4  32  4 
SVARM 2004-033    248  >128 8  1  >128 ≤0.5 ≤0.25 4  32  4 
SVARM 2004-076    248  >128 4  1  >128 ≤0.5 ≤0.25 4  32  4 
SVARM 2004-079    248  >128 4  1  >128 ≤0.5 ≤0.25 4  32  4 
SVARM 2004-262    248  >128 4  1  128 ≤0.5 ≤0.25 4  32  8 
SVARM 2004-312    248  >128 8  1  128 ≤0.5 ≤0.25 4  32  4 
SVARM 2004-313*    248  >128 4  1  >128 ≤0.5 ≤0.25 2  32  4 
SVARM 2005-053    248  >128 4  ≤0.5 >128 1  ≤0.25 2  32  4 
SVARM 2007-333    248  >128 4  1  128 ≤0.5 ≤0.25 4  32  8 
SVARM 2009-091    248  >128 4  1  >128 ≤0.5 ≤0.25 2  32  8 
SVARM 2004-133*    310  >128 8  1  >128 ≤0.5 ≤0.25 2  32  4 
SVARM 2002-073    587  >128 4  ≤0.5 128 ≤0.5 4  4  32  4 
SVARM 2002-304*    587  >128 4  ≤0.5 128 ≤0.5 4  4  32  4 
FAIR sb024    9  >128 8  ≤0.5 16  64  2  2  64  8 
FAIR sb036    9  >128 8  1  16  >64 4  2  64  8 
FAIR sb052*    9  >128 8  1  16  >64 4  2  64  8 
SVARM 2002-137    9  >128 4  1  8  64  2  2  64  8 
SVARM 2000-172*    370  >128 8  1  64  64  2  1  64  8 
SVARM 2000-247*    13  >128 4  >64 ≤1  ≤0.5 ≤0.25 64  64  8 
¤ = the representative of the clone that dominates among VRE from Swedish broilers. 
* = isolates chosen as clone representatives 
Shaded fields indicate MIC above the epidemiological cut off values issued by EUCAST 
(2011). 
Antimicrobials included and cut of values (mg/L) used are vancomycin (Va, >4), narasin (Na, 
>2), erythromycin (Em, >4), bacitracin (Ba, >32U), tetracycline (Te, >2), ampicillin (Ap, 
>4), virginamycin (Vm, >4), streptomycin (Sm, >512) and gentamicin (Gm, >32). 
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Discussion 
Vancomycin resistance was transferred from the predominant as well as from 
five of the minority clones and at frequencies similar to or lower than 
reported elsewhere (Rosvoll et al., 2010; Jung et al., 2006; Lester et al., 
2006; Sundsfjord et al., 2001). Thus, the predominance of one clone among 
VRE in Swedish broiler production is not due to that clones’ inability to 
transfer the vancomycin resistance. Furthermore, as the vanA gene was 
transferrable from the predominant clone it is likely that any given VRE 
from Swedish broilers will have vancomycin resistance that is transferrable to 
other enterococci. Thereby they constitute a reservoir with the potential for 
zoonotic spread of vancomycin resistance, as described previously for VRE 
of broiler origin (Lester & Hammerum, 2010; Lester et al., 2006). However, 
VRE in Swedish healthcare are mainly E. faecium with the vanB gene 
(SWEDRES, 2010). Hence, neither the abundance of VRE in production 
animals in other parts of Europe in the 1990’s nor the presence of VRE in 
Swedish broiler production seems to have affected the situation in Swedish 
healthcare to a greater extent. 
Even if presence of several clones of VRE in Swedish broilers is in 
accordance with reports from other parts of Europe, the predominance of 
one clone is not (Garcia-Migura et al., 2007b; Novais et al., 2005; Sorum et 
al., 2004; Heuer et al., 2002). The predominant and the minority clones are 
similar in that vancomycin resistance is plasmid mediated and that all but 
one of the minority clones carries the BM4147 prototype variant of the 
Tn1546 transposon. The plasmid localization of the vanA gene and to some 
extent also the predominance of the prototype variant of the Tn1546 
transposon are in accordance with previous knowledge (Biavasco et al., 
2007; Courvalin, 2006; Jung et al., 2006; Woodford et al., 1998). 
Between one and four plasmids were seen in the S1 analysis and the only 
plasmid replicon type detected was pRE25 but only in six of the eleven 
clones. Both the presence of pRE25 and the number of plasmids are in 
accordance with what has been described elsewhere in E. faecium from 
animals (Rosvoll et al., 2010). Furthermore, the pRE25 plasmid has been 
associated with transferable vancomycin resistance in E. faecium (Garcia-
Migura et al., 2007a). In two of the transconjugants the pRE25 plasmid 
replicon type was also detected, indicating a connection to the vancomycin 
resistance in these clones. The indication was especially strong for isolate 
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SVARM 2002-304 and its respective transconjugant where the pRE25 
replicon type was detected and only one plasmid (of about 57.5 kb) was 
seen in the S1 analysis. Even if not confirmed, it is probable that the visible 
plasmid is indeed of the pRE25 plasmid replicon type and mediating 
vancomycin resistance. 
Presence of plasmid addiction systems has been described in both 
vancomycin susceptible and resistant enterococci of human as well as animal 
origin (Rosvoll et al., 2010; Moritz & Hergenrother, 2007; Johnsen et al., 
2005; Grady & Hayes, 2003). Persistence of VRE in the absence of selective 
pressure has been suggested to be associated with linkage of the vanA gene 
and the ω-ε-ζ system (Johnsen et al., 2005). But this does not seem to be the 
situation in Sweden since the axe-txe system was not detected in any, and 
the ω-ε-ζ system in only one of the minority clones. Besides, the ω-ε-ζ 
system was not co-transferred with vancomycin resistance indicating that 
they are not located on the same plasmid. It is therefore unlikely that the 
investigated plasmid addiction systems play such an important role in VRE 
epidemiology among Swedish broilers as has been suggested for ω-ε-ζ in 
Norway (Johnsen et al., 2005). 
Decreased susceptibility to narasin was co-transferred with vancomycin 
resistance from the predominant and three of the minority clones. To our 
knowledge, transferrable resistance for an ionophore has not been previously 
described. Furthermore, decreased susceptibility to narasin is widespread 
among vancomycin susceptible as well as resistant enterococci from Swedish 
broilers (SVARM, 2010). Hence, use of narasin is not expected to select for 
VRE (Nilsson et al., 2009b). However, co-transfer of the vanA gene and 
decreased susceptibility to narasin indicates that use of narasin may play a 
role in persistence of vancomycin resistance among enterococci in Swedish 
broilers. The mechanism of the decreased susceptibility to narasin and its 
connection to the vancomycin resistance gene remains to be clarified but 
perhaps the traits are closely linked to each other. Thus, when retaining the 
decreased susceptibility to narasin the enterococci also retain the 
vancomycin resistance. 
In conclusion, the predominance of one clone among VRE in Swedish 
broiler production is not due to inability of that, or other clones to transfer 
the  vanA gene. Nor is the predominance explained by other molecular 
similarities or dissimilarities among the clones because there does not seem 
to be any correlations regarding the differences. That the vancomycin 
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resistance is transferrable from the predominant clone and several of the 
minority clones confirms that VRE among Swedish broilers constitutes a 
pool of resistance genes with the potential to disseminate to other 
enterococci, including those colonizing humans. But so far the presence of 
VRE among Swedish broilers does not seems to have affected the situation 
in Swedish health care where the majority of VRE are E. faecium, vanB 
(SWEDRES, 2010). Finally, the coincidental finding that decreased 
susceptibility to narasin can be co-transferred with the vanA gene raises 
questions on the role of narasin in the persistence of vancomycin resistance 
in enterococci in Swedish broilers. To completely clarify the role of narasin, 
experimental studies as well as genetic investigations are probably needed. 
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Abstract 
The proportion of broilers in Sweden colonized with vancomycin resistant 
enterococci (VRE) increased rapidly from 2000 to 2005 but has since then 
stabilized. Presence of VRE among Swedish broilers is unwanted since they 
constitute a pool of resistance that could affect the situation in human 
healthcare. Enterococci are robust bacteria that can survive adverse 
conditions and VRE in Swedish broiler production has been shown to 
persist at farms between batches. The aim of this study was therefore to (i) 
determine the ability of VRE from Swedish broilers to withstand various 
physical conditions including exposure to disinfectants under laboratory 
conditions and, (ii) test the applicability of the laboratory findings in a pilot 
study on disinfection of farms. 
The laboratory studies confirmed that VRE from Swedish broilers can 
withstand harsh conditions, grow in various temperatures and survive for 
long periods. The tested isolates did however seem fully susceptible to the 
tested disinfectants. This indicates that a reduction of VRE contamination in 
the broiler houses is possible, provided that cleaning and disinfection can be 
adequately performed. 
In the field disinfection pilot study, two variants of a disinfection protocol 
combining steam and formaldehyde was tested at two different farms. After 
the disinfection, VRE could not be detected in environmental samples from 
the test compartments but was detected in environmental samples from the 
control compartments. The proportion of broilers colonized with VRE did 
however decrease in both the test and the control compartments making the 
effect of the disinfection on the proportion of broilers colonized with VRE 
inconclusive. Still, the results are promising and indicate that the occurrence 
of VRE can be reduced by adequate cleaning and disinfection. 
2 
Introduction 
Prevalence of vancomycin resistant enterococci (VRE) among randomly 
selected enterococci from Swedish broilers is very low (SVARM, 2010). 
However, the proportion of Swedish broilers colonized with VRE increased 
rapidly from 2000 to 2005 (Nilsson et al., 2009b). The increase was due to 
the spread of one major clone of vanA carrying Enterococcus faecium with 
multi locus sequence type 310 (MLST ST310). The factor(s) that caused this 
spread of one clone is not known but use of antimicrobials is limited in 
Swedish broiler production and the glycopeptide growth promoter 
avoparcin was only used during the late 1970s and early 1980s (Bager et al., 
1997; Wierup et al., 1987). As VRE are important causes of nosocomial 
infections (Werner et al., 2008) presence of VRE in farm animals is 
unwanted since they constitute a pool of resistance that could affect the 
situation in human healthcare. The risk of such a transmission was the 
justification for discontinuing the use of avoparcin in the European Union 
in 1997 (Commission Directive 97/6 EC). 
Within the Swedish broiler production, an all-in all-out procedure with 
thorough cleaning and disinfection between all batches is practiced. 
However, enterococci are robust bacteria that can survive adverse 
conditions (Barnes, 1959) and the clone of VRE dominating in Swedish 
broiler production (ST310) has been shown to persist at farms (Nilsson et al., 
2009a). It has also been shown that there is no constant introduction of 
VRE, neither from the hatcheries nor from the feed (Nilsson et al., 2008). 
Together this indicates that if VRE could be eliminated from the farms, the 
proportion of broilers colonized with VRE would probably also decrease. 
However, no clear differences in management routines between Swedish 
farms contaminated and not contaminated with VRE have been found 
(Jansson et al., 2009). This could indicate that none of the cleaning and 
disinfection routines normally used is sufficiently effective, perhaps due to 
properties of the bacteria (e.g. resistance to disinfectants) or to practical 
difficulties in the application of disinfection protocols (e.g. assuring that the 
disinfectant reach into all cracks and all equipment). The aim of this study 
was therefore to (i) determine the ability of VRE from Swedish broilers to 
withstand various physical conditions including exposure to disinfectants 
under laboratory conditions and, (ii) test the applicability of the laboratory 
findings in a field disinfection pilot study. 
3 
Materials and Methods 
Laboratory studies 
Three VRE from caecal samples of healthy broilers (VRE:2000-172, 
VRE:2000-247, and VRE:2001-233), obtained and typed through the 
Swedish Veterinary Antimicrobial Resistance Monitoring (SVARM) 
programme (SVARM, 2010) were investigated. All three had previously 
been shown to be of different MLST types, including the dominating 
ST310 (in order as above: ST370, ST13 and ST310) (Nilsson et al., 2009b). 
In all tests, either 4-h or 15-h pre-cultures of each isolate were used. Pre-
cultures were prepared by suspending material from 3-5 fresh overnight 
colonies in 5 mL Mueller-Hinton broth (Difco, Sparks, USA) and 
incubating at 37°C for 4 or 15 h. All tests were performed in triplicates. 
To test growth at different physical conditions (pH and temperature), a 4-h 
pre-culture was stepwise diluted 1:10
6 in Mueller-Hinton broth (Difco) and 
incubated for 18 h, either at 37°C or at the test temperature (i.e. 45, 47, 49, 
or 50°C ). For tests regarding pH; the broth was adjusted to pH 4, 5 or 6 
with HCl and pH 9 or 10 with NaOH. Growth was determined as visible 
turbidity. 
To test survival at different temperatures, a 15-h pre-culture was stepwise 
diluted 1:10
6 in Mueller-Hinton broth (Difco), pipetted to empty Petri 
dishes (0.1 mL per dish), and left to dry at room temperature in a ventilation 
hood. The number of surviving bacteria in the dishes was determined after 
various times of storage at 6, 21.5 or 31°C (Figure 2a-c). Briefly, bacteria 
were dissolved with 0.1 mL saline solution before Mueller-Hinton-agar 
(Oxoid, Basingstoke, UK) was poured into the dishes. Plates were then 
incubated at 37°C over night before the number of colony forming units 
(CFU) was recorded. Survival curves were plotted as mean logarithmic 
number of CFU versus time in weeks. 
To test tolerance of high temperatures, 50 µL from a 4-h pre-culture was 
inoculated in 5 mL of pre-heated Mueller-Hinton broth (Difco), incubated 
for 4 hours at the test temperature (i.e. 55, 60 or 65°C ), cooled and 
incubated for 18 h at 37°C before growth was determined as visible 
turbidity. 
The susceptibility to three commercial disinfectants: a glutaraldehyde (GLU-
CID; Brenntag Nordic, Ballerup, Denmark), a combination of peroxygen 
4 
and an organic acid (Virkon-S
®; Antec International, Suffolk, England), and 
a formaldehyde (Formalin; Merck KGaA, Darmstadt, Germany) was tested. 
The disinfectants were chosen since they are commonly used in Swedish 
broiler production. Susceptibility to GLU-CID and Virkon-S
® was tested 
with a quantitative suspension test as described by Reybrouck (2004) 
whereas the susceptibility to Formalin was tested by exposing bacteria to 
gaseous formaldehyde. As “test suspension” for both tests, a 15-h pre-
culture was mixed 1:1 with a soiling solution containing bovine serum 
albumin (10 g/L, Sigma-Aldrich) and yeast extract (10 g/L, Difco). For the 
quantitative suspension test, the test suspension was exposed to the 
disinfectants, neutralized with a quenching agent [0,1% Pepton (Difco), 
0,5% Tween 80 (Merck, Darmstadt, Germany), 0,1% Natriumthiosulfat 
(Fluka, Steinheim, Germany) and 0,07% Lecitin (Sigma-Aldrich) in Super 
Q water (Johnston & Jones, 1995)], serially diluted and cultured on blood 
agar (Oxoid) to determine the number of colonyforming units per milliliter 
(CFU/mL). Before the tests, the efficacy of the quenching agent to the two 
disinfectants had been verified (data not shown). For the exposure to 
gaseous formaldehyde, 0.1 mL of test suspension was pipetted to empty 
Petri dishes and left to dry at room temperature in a ventilation hood before 
test plates were placed in a room fumigated over night with 5.33 mL of 
Formalin (40%) per cubic meter. The number of surviving bacteria in test 
and control dishes was determined in the same way as for survival in 
different temperatures. 
Field disinfection experiments 
Two farms previously having had broilers colonized with VRE were 
chosen. After the broilers had been sent to slaughter, the houses were either 
cleaned and disinfected according to the farm’s normal routines (control 
compartments) or cleaned according to the farm’s normal routines and 
disinfected with a combination of steam and formaldehyde (test 
compartments), as outlined by Gradel et al. (2004a). 
At Farm A; two compartments in one house were used as test compartments 
and disinfected at a temperature of 50°C for 4h and two compartments in an 
identical house were used as control. At Farm B; a single compartment 
house was used as test compartment and disinfected at a temperature of 
60°C for 4h whereas two compartments in one house (each of the same size 
as the test compartment) was used as control. The size of the test 
compartments were approximately 1900 square meters (5700 cubic meters) 
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at Farm A and 1600 square meters (4800 cubic meters) at Farm B. At both 
farms was 90 g of Formalin per cubic meter used. 
From one (Farm A) and two (Farm B) batches of broilers sent for slaughter 
preceding the disinfection and the two batches’ after the disinfection, caecal 
samples from ten birds per house or compartment were analyzed for the 
presence of VRE as previously described (Nilsson et al., 2009a; Nilsson et 
al., 2009b). In addition, environmental samples (air inlet, feed line and water 
line) from each compartment were collected before and after disinfection in 
the test compartments and at corresponding time points in the control 
compartments. All environmental samples were taken in duplicate except 
samples from the water line after disinfection at Farm A. Environmental 
samples were collected with sterile cloths and cultured for qualitative 
detection of VRE as previously described (Nilsson et al., 2009a). From each 
sampling occasion, one isolate was selected at random for species 
identification and susceptibility testing as previously described (Nilsson et al., 
2009b; Devriese et al., 1993). Caecal samples from broilers raised at Farm A 
could only be identified by house and not by compartment and therefore all 
samples were grouped accordingly. Furthermore, boxes in which the 
chickens for the batch directly following the disinfection were delivered 
were sampled and cultured as the environmental samples. At Farm A, ten 
boxes from each house were sampled whereas at Farm B only nine boxes in 
total were sampled since the day old chickens for both test and control 
compartments were of the same consignment. 
Results 
Laboratory studies 
All three isolates grew at 45 and 47°C but none grew at 49 or 50°C. All 
three isolates grew in pH 6 and 9, VRE:2001-233 and VRE:2000-172 grew 
in pH 5 but not VRE:2000-247 and none of the isolates grew in pH 4 or 
10. All isolates survived for 20 weeks in all temperatures (Figure 1a-c). 
Furthermore, only for VRE:2000-247 stored at 6°C did the mean reduction 
in viable CFU exceed 1 log during the period studied (Figure 1a). All 
isolates tolerated 55°C for 4h; both VRE:2000-172 and VRE:2000-247 
tolerated 60°C for 4h but only in one of the triplicates; and only 
VRE:2000-247 tolerated 65°C for 4h, also then only in one of the 
triplicates. 
6 
No differences in susceptibility towards the tested disinfectants were 
detected among the isolates. Bacteria could not be reisolated from any of the 
samples treated with disinfectant. In the control samples, the amount of 
bacteria varied between 4.8 and 5.6 log CFU/mL (means 5.0 to 5.4 log 
CFU/mL) for the quantitative suspension test and 2.1 and 2.6 log CFU/mL 
(means 2.1 to 2.5 log CFU/mL) for the exposure to gaseous formaldehyde. 
 
Figure 1. Survival of strains at 6°C (a), 
21.5°C (b) and 31°C (c). Mean logarithmic 
changes of viable colony forming units 
(CFU) and standard deviation in 
comparison to the amount at the beginning 
of the experiment on vertical axes and time 
of storage (weeks) on horizontal axes. Mean 
initial number of viable CFU varied from 
log 2.1 to 2.6. Strains: (▲) VRE:2001-233, 
(■) VRE:2000-172 and (●) VRE:2000-247. 
 
Field disinfection experiments 
Isolation of VRE 
The proportion of caecas positive for VRE varied among sampling 
occasions (Table 1). Notably, one of the caecas from broilers raised in the 
test compartments after disinfection at Farm A was positive for VRE. Also 
the proportion of environmental samples from which VRE was isolated 
varied but none of the samples taken from the test compartments after the 
disinfection were positive (Table 1). VRE was not isolated from any of the 
samples taken from the boxes in which the chickens were delivered. All 
isolates chosen for species identification and susceptibility testing were E. 
faecium and the MIC of vancomycin for these isolates was >128 mg/L. 
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Discussion 
The overall aim of this study was to find ways to decrease the level of VRE 
contamination in the environment at broiler farms and thereby also lower 
the proportion of broilers colonized with VRE at slaughter. All together, 
the results are promising and indicate that occurrence of VRE can be 
reduced by adequate cleaning and disinfection. 
The laboratory studies detected no substantial differences among the 
investigated isolates, even if there were some variations in the fitness. For 
example, only the isolate of the dominating clone (VRE:2001-233) showed 
visible growth in Mueller-Hinton broth with 6% NaCl, but that isolate was 
the least tolerant to high temperatures. All isolates survived storage at all 
temperatures for the whole period of 20 weeks and generally showed less 
than 0.5 log reductions in CFU during storage. Hence, it is likely that they 
survive longer. The length of survival was comparable to or longer than in 
other studies (Ramadhan & Hegedus, 2005; Neely & Maley, 2000; Wendt 
et al., 1998; Bale et al., 1993). However, in some of those studies, as in our, 
some isolates survived for the full length of the experiment. Hence, definite 
conclusions on the full potential for survival of different enterococci cannot 
be drawn. 
Decreased susceptibility to disinfectants has been described in various 
bacteria and sometimes also in association with antibiotic resistance (Cerf et 
al., 2010; SCENHIR, 2009; EFSA, 2008). We detected no decreased 
susceptibility to the disinfectants. Thus, failure to reduce contamination 
with VRE at farm level probably lies in difficulties to fully apply to the 
disinfection protocols rather than in the protocols per se (Cerf et al., 2010; 
Weber & Rutala, 2006). For example, practical difficulties in cleaning the 
houses adequately can lead to quenching of the disinfectant by remaining 
biological substances. Also difficulties in applying the disinfectant at various 
locations within the houses could contribute to the unsuccessful 
disinfection. Therefore we decided to test a new disinfection method rather 
than a new disinfectant in the field disinfection pilot study. 
The efficacy of the chosen method towards enterococci had been shown 
under both laboratory and field conditions (Gradel et al., 2004a; Gradel et 
al., 2004b). Furthermore, the financial cost of the method was acceptable for  
practical use. For example, the cost of the disinfection in this study was 
9 
approximately 4000 euro per farm. Both temperatures, i.e. 50 and 60°C, 
tested in the pilot study reduced the amount of VRE after disinfection 
below the detection limit of the methodology for environmental samples. In 
contrast, VRE were still isolated after disinfection by the farms’ normal 
routines. It has recently been suggested that it will take decades for VRE to 
disappear from farms even without the selective pressure of glycopeptides 
(Johnsen et al., 2011). No interventions were however included in that 
prediction but the present study indicates that VRE persisting in the broiler 
houses can be removed. A reduction of VRE contamination in the broiler 
houses could lead to fewer birds colonized and consequently to further 
reduction of VRE occurrence in the broiler houses. Furthermore, that the 
effectiveness of tested disinfection method against VRE indicates that it can 
also be used for other agents since enterococci are known to be robust 
bacteria. 
At Farm B, the reduction of VRE contamination in the compartments was 
reflected by the culture of samples of caecal content from broilers raised after 
disinfection. In the test house, VRE was not isolated from the two batches 
of broilers raised after disinfection. In contrast, from the two control 
compartments, VRE was isolated both from both the first and the second 
batch from one of the compartments but not in the other compartment. 
However, at Farm A VRE was isolated from one sample from the first batch 
of broilers raised in the test compartments after disinfection but in no sample 
from the second batch. Notably, VRE was not isolated in samples from the 
first batch raised in the control compartments after disinfection, but from 
one csample from the second batch. The difference in proportion of samples 
positive for VRE between the farms indicates that the disinfection was more 
efficient at Farm B. This could possibly be attributed to the higher 
temperature used at Farm B but could also be due to other differences 
between the farms. The varying results regarding proportion of caecas 
positive for VRE between test and control compartments at Farm A can be 
due to lack of sensitivity in the sampling and culturing procedure as well as 
to the fact that the field disinfection experiments only involved two trials. 
However, cross contamination from other houses at the farm is another 
plausible explanation. Similar inconsistencies were also experienced by 
Gradel et al. when developing the disinfection method (Gradel et al., 2004a; 
Gradel et al., 2004b). 
10 
In conclusion, no substantial differences in the ability to withstand various 
physical conditions in vitro among the investigated isolates were detected and 
resistance to disinfectants does not seem to be the reason for persistence of 
VRE at farms. The field experiment was a pilot study to assess whether a 
new disinfection protocol can enable the elimination of VRE at farm level. 
The result of the field experiment was not conclusive since the proportion 
of chickens colonized with VRE diminished also in the control 
compartments. The environmental sampling did however show that 
disinfection with a combination of steam and formaldehyde is more efficient 
in reducing the level of VRE contamination than the farms’ normal 
disinfection routines, thereby indicating that occurrence of VRE can be 
reduced by adequate disinfection. 
Further work to elucidate the possibility to control VRE in Swedish broiler 
production could include large scale disinfection studies were all of the 
houses at farms are disinfected. In addition, better knowledge regarding the 
molecular characteristics (e.g. location and transferability) of the vancomycin 
resistance of VRE from Swedish broilers would be valuable to understand 
why a clone is dominating and to evaluate the risk of transfer and spread of 
the resistance genes. 
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